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 ABST RACT 
 
I n t r o d u c t i o n  
H u ma n  i m m u n o d e f i c i e n c y  v i r u s  ( HIV)  i n f ec t i on  i s  becomi ng  a  
g l o b a l  ep i d e mi c .  I n  H IV - i n fe c t e d  i n d i v i d u a l s ,  a n o r e c t a l  
d i s ea se s  a r e  common  and  t he  commone s t  i nd i ca t i ons  fo r  
su rg i ca l  i n t e rven t i on .  Howe ve r ,  i t  h a s  n o t  b e e n  c l e a r  w h e t h e r  
t h e  ca u se  a n d  ma n a g e me n t  o f  a n or e c t a l  c on d i t i o ns  d i f f e r  i n  
p a t i e n t s  w h o  a r e  H I V  n e g a t i v e  a n d  t h o s e  w h o  a r e  H I V  p o s i t i ve .   
 
A im  
T o  c o mp a r e  t h e  p r e s e n t a t i o n  o f  p e r i a n a l  d i s e a s e s  i n  H I V  + v e  
and  HIV  –ve  pa t i en t s  and  t o  de t e rmi n e  t h e  b e s t  t h e r a p y  fo r  
p e r i a na l  d i s e a s e s  i n  H I V  + v e  p a t i e n t s  
  
M e t h o d s   
The  s t udy  pe r i od  was  f rom 1999  t o  2 0 0 2 .   P a t i e n t s  s e e n  a t  
He l en  Jo seph  Hosp i t a l  du r ing  t he  a u t h o r ’ s  g a s t r o e n t e r o l o g y  
f e l l owsh ip  pe r i od  and  t hose  f r o m h i s  p r i v a t e  p r a c t i c e  w e r e  
r e c r u i t e d .  T h o s e  w h o  a g r e e d  t o  H I V  t e s t i n g  a n d  w h o  w e r e  
t r e a t e d  b y  t h e  a u t h o r  w e r e  i n c l u d e d  i n  t h e  s t u d y .  T h e  p a t i e n t s  
w e r e  c a t e g o r i z e d  a c c o r d i n g  t o  H I V  s t a t u s ,  CDC  c l a s s i f i c a t i o n  
a n d  p e r i a n a l  p a t h o l o g y .  S t a n d a r d i ze d  q u e s t i o n n a i r e s  w e r e  u s e d   
 
 VI
fo r  e v e r y  p a t i e n t .  P a t i e n t s  w e r e  r ev i ewed  eve ry  two  weeks  a f t e r  
t he  p rocedu re  un t i l  f i t  f o r  d i s c h a r g e .   
  
R e s u l t s   
T h e  s a mp l e  c o mp r i s e d  2 4 1  p a t i e n t s :  1 0 0  H I V + v e  ( 6 3  ma l e s  a n d  
3 7  f e ma l e s )  a n d  1 4 1  H I V - v e  ( 6 1  m a l e s  a n d  8 0  f e ma l e s ) .  T h e  
me a n  a g e  o f  t h e  H I V + v e  p a t i e n t s  w a s  3 4 , 8 y  ( r a n g e  1 7 - 6 2 y ) ,  a n d  
t h e  me a n  a g e  o f  t h e  H I V - v e  p a t i e n t s  w a s  4 1 y  ( r a n g e  5 - 8 2 y ) .  
F o l l o w - up  w a s  f r o m t w o  w e e k s  t o  t w o  y e a r s .  T h e  p a t h o l o g y  
i n c l u d e d  6 2  ( 2 5  + v e ,  3 7  - v e )  h a e mo r r h o i d s ,  6 7  ( 2 7  + v e ,  4 0  – v e )  
f i s t u l a s ,  5 9  ( 2 5  + v e ,  3 4  - v e )  a b s c e s s e s ,  4 6  ( 1 1  + v e ,  3 5  - v e )  
f i s s u r e s ,  2 4  ( 2 2  + v e ,  2  - v e )  a n a l  u l c e r s ,  f o u r  ( 3  + v e ,  1  - v e )  a na l  
w a r t s ,  t wo  ( b o t h  + v e )  p i l o n i d a l  s i n u s e s ,  t h r e e  ( a l l  - v e )  a n a l  
c a n c e r s  a n d  t w o  ( 1  + v e ,  1  - v e )  h id r aden i t i s  suppu ra t i va .  N ine  
p a t i e n t s  w i t h  h a e mo r r h o i d s  (4+ve ,  5 -ve )  we re  t r e a t ed  
c o n s e r v a t i v e l y ,  1 1  p a t i e n t s  w i t h  haemor rho id s  ( 6+ve ,  5 -ve )  had  
rubbe r  band  l i ga t i on  and  42  pa t i en t s  w i t h  h a e m o r r h o i d s  ( 1 5 + v e ,  
2 7 - v e )  h a d  h a e mo r r h o i d e c t o m y .  T h i r t e e n  p a t i e n t s  ( 1 + v e ,  1 2 - v e ;  
p < 0 . 0 0 1 )  h a d  c o m p l e x  f i s t u l a s  a n d  8  p a t i e n t s  ( 7 + v e ,  1 - v e ;  
p = 0 . 0 0 6 )  h a d  mu l t i p l e  f i s t u l a s .  T e n  H I V  - v e  p a t i e n t s  w i t h  
c o mpl e x  f i s t u l a s  a n d  s e v e n  p a t i en t s  w i th  t r an s - sph inc t e r i c  
f i s t u l a s  ( 3 + v e ,  4 - ve )  n e e de d  mor e  t h a n  s i x  we e k s  t o  he a l  a f t e r  
t r e a t me n t .  T h i r t y  p a t i e n t s  w i t h  a na l  f i s s u r e s  h a d  s e n t i n e l  p i l e s ,  
b u t  t h e r e  w e r e  n o n e  i n  t h e  p a t i en t s  w i th  ana l  u l ce r s  ( p<0 .0001 ) .   
 VII
 T h i r t e e n  H I V  + v e  p a t i e n t s  w i t h  a n a l  u l c e r s  h a d  a n  a b n o r ma l l y  
weak  ana l  t one ,  bu t  on ly  one  HIV  + v e  p a t i e n t  w i t h  a n a l  f i s s u r e   
h a d  a  we a k  a n a l  t o n e  ( p < 0 . 0 0 1 ) .  I n  t h e  p a t i e n t s  w i t h  a n a l  
f i s s u r e ,  3 7  ( 8 + v e ,  2 9 - v e )  h a d  a  h igh  ana l  t one ,  bu t  none  o f  t he  
pa t i en t s  w i th  ana l  u l ce r s  had  i nc r ea sed  ana l  t one  (p<0 .0001 ) .  
Of  t he  59  pa t i en t s  w i th  pe r i ana l  suppu ra t i on ,  23  (8+ve ,  15 -ve )  
h a d  p r i ma r y  f i s t u l o t o my  a s  w e l l  a s  d r a i n a ge  o f  t h e  a b s ce s s .   
 
C o n c l u s i o n s  
M u l t i p l e  f i s t u l a s  w e r e  mor e  c o m mo n l y  s e e n  i n  a d v a nc e d  H I V  
p a t i e n t s ,  w h e r e a s  c o m p l e x  f i s t u l a s  w e r e  mor e  c o m m o n l y  s e e n  i n  
H I V  n e g a t i v e  i n d i v i d u a l s .  H e a l i n g  a f t e r  f i s t u l a  s u rge r y  i s  
d e t e r mi n e d  mor e  b y  t h e  t y p e  o f  f i s t u l a  t h a n  t h e  H I V  s t a t u s  o r  
s t a g e .  
A n a l  f i s t u l a s  a s s o c i a t e d  w i t h  pe r i ana l  suppu ra t i on  can  be  
t r e a t e d  t h e  s a me  w a y  i n  b o th  HIV  nega t i ve  and  pos i t i ve  
p a t i e n t s ,  w i t h o u t  i n c r e a s e d  c o mp l i c a t i o n s .  
C a r e f u l  p h y s i c a l  e x a mi n a t i o n  i s  e s s e n t i a l  t o  d i f f e r e n t i a t e  
b e t w e e n  a n a l  u l c e r s  a n d  f i s s u r e s .  B o t h  c o n d i t i o n s  a r e  c o m m o n ,  
a n d  h a v e  s i mi l a r  sy mp t o ms  i n  H I V  po s i t i ve  pa t i e n t s .  Th e y  c a n ,  
howeve r ,  be  r ead i l y  and  s a f e ly  d i s t i ngu i shed  on  c l i n i ca l  
e x a mi n a t i o n ,  s i n c e  f i s s u r e s  a r e  a s s oc i a t ed  w i th  h igh  ana l  t one ,   
 VIII
a n d  a  s e n t i n e l  p i l e ,  w h i l e  t h e  A I D S  u l c e r  l ac k s  t h e  s e n t i n e l  
p i l e ,  a n d  t h e  p r e s s u r e  i s  l o w .  
Ana l  ma l i gnanc i e s ,  e spec i a l l y  squamous  ce l l  c a r c inoma ,  have  
b e e n  u n c o m mo n  i n  o u r  e x p e r i e n c e .  
Wi t h  t h e  a d d i t i o n  o f  a n t i - r e t r o v i r a l  t h e r a p y  a n d  a n t i b i o t i c s ,  
h a e mo r r h o i d s  ma y  b e  s a f e l y  t r e a t e d  a c c o r d i n g  t o  s t a n d a r d  
p r i n c i p l e s  ( r u b b e r  b a n d  l i g a t i on  and  haemor rho idec tomy ,  a s  
a p p r o p r i a t e ) .  
O u r  p r a c t i c e  h a s  f a v o u r e d  a  c o n se r v a t i v e  a p p r o a c h  i n  p a t i e n t s  
w i t h  a d v a n c e d  H I V  d i s e a s e .  H o w e v e r ,  a n t i - r e t r o v i r a l  t h e r a p y  
a n d  a n t i b i o t i c s  ma y  i mp r o v e  t h e  s a f e t y  a n d  o u t c o me  a f t e r  
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 1  I N T R O D U C T I O N  
 
H u ma n  i m m u n o d e f i c i e n c y  v i r u s  ( HIV)  i n f ec t i on  i s  becomi ng  a  
g l o b a l  e p i d e mi c .  A c c o r d i ng  t o  a n  e s t i ma t e  o f  t h e  g l o b a l  H I V  
s i t u a t i o n  ma d e  b y  t h e  j o i n t  U n i t ed  N a t i o n s  P r o g r am m e  o n  
HIV/AIDS  (UNAIDS)  and  t he  W o r l d  H e a l t h  O r g a n i z a t i o n  
( WH O ) ,  n e a r l y  30  mi l l i on  a d u l t s  a n d  c h i l d re n  h a v e  b e e n  
i n f e c t e d  w i t h  H I V . 1  I n  S o u t h  A f r i c a ,  1 8 . 8 %  o f  g e n e r a l  
p o p u l a t i o n  a n d  2 4 %  t o  3 0 %  o f  p r e g n a n t  w o me n  a r e  H I V  
pos i t i ve  (da t a  cou r t e sy  o f  Re p r o d u c t i v e  H e a l t h  a n d  H I V  
R e s e a r c h  U n i t ,  U n i v e r s i t y  o f  t h e  Wi t w a t e r s r a n d ) .  H o w e v e r ,  
me d i c a l  a n d  s u r g i c a l  t h e r a p i e s  f o r  t h e s e  p a t i e n t s  h a ve  
d r a ma t i c a l l y  i mp r o v e d  r e c e n t l y  a s  t h e  r e s u l t  o f  t h e  a d v e n t  o f  
c o mbi n a t i o n  a n t i - r e t r o v i r a l  d r u g  r e g i me n s . 2 , 3   
A n o r e c t a l  d i s e a s e s  a r e  c o m m o n  i n  H I V - i n f e c t e d  i n d i v i d u a l s  a n d  
a r e  t h e  co m mo n e s t  i n d i c a t i o n s  fo r  s u r g i c a l  i n t e r v e n t i on  i n  t h e s e  
p a t i e n t s .  F o r  s o me ,  a n o r e c t a l  s ymp t o ms  ma y  r e p r e se n t  t h e  f i r s t  
ma n i f e s t a t i o n  o f  t h e  H I V - i n f e c t i o n .  Re c u r r e n t  a n o r e c t a l  d i s e a s e  
a s s o c i a t e d  w i t h  s y s t e mi c  s y m p t o ms  ma y  i n d i c a t e  t he  p o s s i b i l i t y  
o f  A I D S .  C y c l o me g a l o v i r u s  ( C M V ) ,  f u n g a l  o r  c h r o n i c  p e r i a n a l  
h e r p e s  s i m p l e x  i n f e c t i o n  l a s t i n g  mo r e  t h a n  o n e  mo n t h ,  o r  
a n o r e c t a l  l y mp h o ma  o r  K a p o s i ’ s  s a r c o ma  i n  t h e  p r e s e n c e  o f  
H I V  a n t i b o d y  s e r op o s i t i v i t y  e s t a b l i s he s  t h e  d i a g n o s i s  o f  A I D S . 4    
 
 1
 I t  h a s  no t  b e e n  c l e a r  w h e t h e r  t h e  c a u s e  a n d  ma n a g e me n t  o f  
ano rec t a l  cond i t i ons  d i f f e r  i n  pa t i en t s  who  a r e  HIV  nega t i ve  
and  t hose  who  a r e  HIV  pos i t i ve .   
T h e r e  a r e  a l s o  v a r i a b l e  r e p o r t s  c o n c e r n i ng  t h e  r e s u l t s  o f  
su rg i ca l  p rocedu re s ,  i nc lud ing  wound  hea l i ng . 5 , 6   Hea l i ng  o f  
a n o r e c t a l  d i s e a s e  a f t e r  s u r g e r y  i s  l a r g e l y  de t e r mi n e d  b y  t h e  
s t age  o f  HIV  in f e c t i on .  I n  e a r l y  r e p o r t s ,  t h e  o v e r a l l  h e a l i n g  r a t e  
a f t e r  s u r g e r y  wa s  e x t r e me l y  poo r .  Rec t a l  pe r fo r a t i on ,  
i ncon t i nence ,  and  pe r s i s t en t  d r a i n a g e  we r e  r e p o r t e d  a s  
c o mpl i c a t i o n s  i n  9 0 %  o f  a l l  d i a g n o s t i c  o r  t h e r a p e u t i c  
p r o c e d u r e s . 7  I n  c o n t r a s t ,  t e n  y e a r s  l a t e r ,  S a fv i  e t  a l  r e p o r t e d  
t h a t  H I V p o s i t i ve  p a t i e n t s  w i t h o u t  A I D S  h a v e  a n  a c c e p t a b l e  
o u t c o me  a f t e r  a n o r e c t a l  s u r g e ry  a n d  t h a t  a  p o o r  o u t c o me  w a s  
m o s t l y  l i mi t e d  t o  t h o s e  w i t h  p r e - e x i s t i n g  A I D S . 8  Howeve r ,  
h e a l i n g  r a t e s  a r e  n o t  u n i f o r ml y  p r e d i c t e d  b y  C D 4  l y m p h o c y t e  
c o u n t s  a l o n e .  S o me  i n d i v i d u a l s  w i th  l ong  s t and ing  HIV  
i n f e c t i o n  r e ma i n  r e ma r k a b l y  w e l l  d e s p i t e  l o w  C D 4  c o u n t s ,  
p e r h a p s  b e c a u s e  o f  a  l o w e r  v i r a l  l o a d  o r  i n f e c t i o n  w i t h  a  l e s s  
v i r u l e n t  s t r a i n  o f  t h e  v i r u s . 9   
Wi t h  i m p r o v e d  r e t r o v i r a l  t h e r a p y ,  H I V - p o s i t i ve  p a t i e n t s  a r e  
a c h i e v i n g  a  l o n g e r  l i f e  e x p e c tancy .  Consequen t l y ,  t he se  
p a t i e n t s  a p p e a r  t o  h a v e  h i g h e r  r i s k  f o r  a n a l  ma l i g n a n c y ,  
e s p e c i a l l y  i n  H I V  p o s i t i ve  h o mos e x u a l  me n 1 0 .  T h e y  d o  p o o r l y   
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w i t h  c o n c u r r e n t  r a d i a t i o n  a n d  c h e mo t h e r a p y ,  u n l e s s  f i r s t  p l a c e d  
o n  a n t i - r e t r o v i r a l  t h e r a p y . 1 1  Whe n  t h e y  u n d e r g o  s u r g e r y ,  t h e r e   
i s  n o t  o n l y  t h e  r i s k  o f  w o u n d  he a l i n g  d i s o r d e r s ,  b u t  a  s h o r t e r  
p o s t - o p e ra t i v e  s u rv i v a l  t i m e  a s  w e l l . 1 1 , 1 2  
C u r r e n t l y ,  t h e  b e s t  ma n a g e me n t  o f  a n o r e c t a l  d i s e a s e s  i n  
p a t i e n t s  i n f e c t e d  w i t h  H I V  i s  u n c l e a r  a n d  t h e  e f f e c t i v e  
ma n a g e m e n t  o f  t h e s e  c on d i t i o ns  p r e s e n t s  t h e  s u r g e o n  a  
c o n s i d e rab l e  c h a l l en g e . 6   
I n  t h e  l i t e r a t u r e ,  o n e  r e c o m me n d a t i o n  f o r  t h e  a p p r o a c h  t o  
a n o r e c t a l  s y mp t o m s  i n  H I V - i n fe c t e d  p a t i e n t s  i s   
“ A l t h o u g h  H A A R T  h a s  d r a ma t i c a l l y  a l t e r e d  t h e  
o c c u r r e n ce  o f  g a s t r o i n t e s t i n a l  c o m p l i c a t i on s ,  
ma n y  o f  t h e  s a me  p r i n c i p l e s  o f  ma n a g e me n t  
e s t a b l i s he d  b e fo r e  H A A R T  r e ma i n  a p p l i ca b l e .  
H e a l i n g  o f  a n o r e c t a l  d i s e a s e s  f o l l ow i n g  s u r g i c a l  
o r  me d i c a l  t h e r a p y  ma y  l a r g e l y  b e  d e t e r mi n e d  b y  
t h e  s t a g e  o f  H I V  i n fe c t i o n .  H I V  p o s i t i ve  p a t i e n t s  
w i t h o u t  A I D S  h a v e  f a v o u r a b l e  o u t c o me s  
f o l l o w i n g  a n o r e c t a l  s u r g e r y  w i t h  a c c e p t a b l e  
w o u n d  h e a l i n g ,  wh e r e a s  p a t i e n t s  wi t h  A I D S  a r e  
m o r e  l i k e l y  t o  h a v e  a  p o o r  o u t c o me ” . 1 3   
 
T h i s  i s  a  v e r y  g e n e r a l  r e c o m me n d a t i o n  a n d  t h e r e  i s  n o  c l e a r  
g u i d e  i n  t h e  c u r r e n t  l i t e r a t u r e  fo r  t h e  t r e a t me n t  o f  p e r i a na l  








 2  STUDY OBJECTIVES 
 
1 .  T o  c o mpa r e  t h e  p r e s e n t a t i o n  o f  p e r i a na l  d i s ea se s  i n  HIV  +ve          
    a n d  H I V  – v e  p a t i e n t s  
2 .  T o  d e t e r mi n e  t h e  o u t c o me  o f  t h e r a p y  f o r  p e r i a n a l  d i s e a s e s  
i n  H I V  + v e  p a t i e n t s  
 
3 . 0  MATERIALS AND METHODS 
 
3 .1  Pa t i en t  s e l ec t i on  
The  s t udy  popu l a t i on  i nc luded  pa t i e n t s  t r e a t e d  b y  t h e  a u t h o r  i n  
t h e  C o l o - r e c t a l  U n i t  a t  H e l e n  J o s ep h  H o s p i t a l  a s  w e l l  a s  i n  h i s  
p r i v a t e  p r a c t i c e  a t  L e s e d i  P r i v a t e  H o s p i t a l  f r o m  1 9 9 9  t o  2 0 0 2 .  
E v e r y  p a t i e n t  w a s  i n f o r me d  a n d  those  who  ag reed  t o  have  t he i r  
da t a  r e co rded  we re  i nc luded  i n  t he  s t udy .   
 
3 . 2  S t u d y  m e t h o ds  
T h e  p a t i e n t s  w e r e  c a t e g or i z e d  a c c o r d i n g  t o  H I V  s t a t u s  a n d  t y p e  
o f  p a t h o l o g y ,  s u c h  a s  haemor rho id s ,  f i s t u l a - i n  ano ,  ana l  f i s su r e ,  
a n a l  u l c e r ,  a n a l  w a r t s ,  p e r i a na l  suppu ra t i on ,  p i l on ida l  s i nus ,  
a n a l  c a n c e r  a n d  h i d r a d e n i t i s  s u p p u r a t i v a .   
E v e r y  pa t i e n t  w a s  i n t e r v i e wed  by  u s ing  s t anda rd i zed  
q u e s t i o n na i r e s  ( A p p e n d i x  B )  r e g a r d i ng  f a e c a l  i n c o n t i n e nc e ,   
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 s e x u a l  be h a v i o u r  i n c l u d i n g  a n a l  r e c e p t i v e  i n t e r c o u r s e  an d  
o b s t e t r i c  h i s t o r y .  
C D C  c l a s s i f i c a t i o n  ( A p p e n d i x  C )  w a s  u s e d  f o r  s t a g i n g  H I V  
p o s i t i ve  p a t i e n t s .  P a t i e n t s  r e c e i ve d  s t a n d a r d  c o u n s e l l i n g  a b o u t  
t he  su rg i ca l  p rocedu re s  app rop r i a t e  i n  t h e i r  c a s e  a nd  h a d  t o  
c o n s e n t  t o  t h e s e  se p a r a t e l y .  
A t  t h e  t i me  o f  t h e  s t u d y ,  t h e  Sou th  Af r i c an  hea l t h  au tho r i t i e s  
h a d  n o t  a p p r o v e d  a n t i - r e t r o v i r a l  t h e r a p y  ( A R T )  f o r  s t a t e  
p a t i e n t s ;  t h u s  o n l y  p r i v a t e  p a t i e n t s  w e r e  o n  t r e a t me n t ,  w h i c h  
w a s  i n i t i a t e d  i f  t h e i r  C D 4  c o u n t  w a s  < 2 5 0 /μL.   
P r o p h y l a c t i c  a n t i b i o t i c s  ( A u g men t i n ® )  w e r e  g i v e n  b e f o r e  
s u r g e r y  a n d  c o n t i n u e d  p o s t -o p e r a t i v e l y  i f  n e c e s s a r y .  
P a t i e n t s  r e c e i v e d  s p e c i a l i s t  c a r e  by  t he  au tho r .  None  o f  t hem 
h a d  a n y  e x p e r i me n t a l  t r e a t m e n t .  
E a c h  o f  t h e m w a s  r e v i e w e d  e v e ry  t w o  w e e k s  a f t e r  t h e  p r o c e d u r e  
u n t i l  f i t  f o r  d i s c h a r g e .  A n y  p o s t - s u r g i c a l  c o mp l i c a t i o n s ,  s u c h  a s  
b l e e d i n g ,  i n c o n t i ne n c e ,  s t r i c t u r e  a n d  s e p s i s ,  w e r e  r e c o r d e d  a t  
e a c h  f o l l o w - u p  v i s i t .  
 
3 .3  End  po in t  o f  s tudy  
T i me  t o  d i s c h a r g e  w a s  d e c i d e d  w h e n  t h e r e  w a s  n o  mor e  p a i n ,  n o  
m o r e  r e c t a l  b l e e d i n g ,  n o  d i s c h a rge  and  no  t ende rnes s  a t  t he  
su rg i ca l  wound .    
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 3 . 4  D a t a  a n a l y s i s  
 
C a s e s  w er e  s t r a t i f i e d  a cc o rd i n g  t o  HIV  s t a tu s .  P r e sen t a t i on ,  
t r e a t me n t  a n d  o u t c o me  w e r e  c o mpa r e d .  M i c r o s o f t  E x e l  a n d  
S t a t i s t i c a  ve r s i on  8  so f twa re  we r e  us e d  t o  c a l c u l a t e  me d i a n s ,  
r a n g e s ,  me a n s ,  S D  a n d  p  v a lue s .  
 
3 . 5  E t h i c s  
 
App rova l  was  ob t a ined  f rom the  Pos tg r adua t e  Commi t t e e  o f  t he  
U n i v e r s i t y  o f  t h e  Wi t w a t e r s r and  and  t he  Hu ma n  Re s e a r ch  
E t h i c s  C o m mi t t e e  ( M e d i c a l )  o f  t he  u n i v e r s i t y  ( M 02- 0 4 - 2 9 )  













 4 . 0  RESULTS AND DISCUSSIONS 
 
A  t o t a l  o f  2 4 1  p a t i e n t s  w e r e  i nc l u d e d  i n  t h e  s t u d y ,  i n  w h i c h  1 0 0  
( 4 1 . 5 % )  w e r e  H I V  p o s i t i ve  a n d  1 4 1  ( 5 8 . 5 % )  w e r e  H I V  n e g a t i ve .  
T h e  me a n  a g e  o f  H I V  p o s i t i v e  p a t i e n t s  w a s  34 , 9  y r  ( r a n g e  1 7 -
6 2 )  a n d  t h e  me a n  a g e  o f  H I V  n e g a t i v e  p a t i e n t s  w a s  4 1 , 0  y r  
( r ange  5 -82 )  ( p<0 .001 ) .  
T h e  H I V  p o s i t i v e  p a t i e n t s  w e r e  e v e n l y  d i s t r i b u t e d  a c r o s s  t h e  
t h r e e  C D C  c l a s s i f i c a t i o ns ,  31%  a t  s t age  I I ,  3 4%  a t  s t a ge  I I I  a n d   
3 5 %  a t  s t a g e  I V .  ( N o t e  t h a t  S t a g e  I  r e f e r s  t o  t h e  c l i n i c a l l y  
u n i d e n t i f i a b l e  s t a g e  o f  e a r l y  i n f e c t i o n . )  
The  pa tho logy  i nc luded  62  ha e mo r r h o i d s ,  6 7  f i s t u l a s ,  5 9  
a b s c e s s e s ,  4 6  f i s s u r e s ,  2 4  a n a l  u l c e r s ,  f o u r  a n a l  wa r t s ,  t w o  
p i l on ida l  s i nuse s ,  t h r ee  ana l  c a n c e r s  a n d  t w o  h i d r a d e n i t i s  
suppu ra t i va .  Dua l  pa tho log i e s  w e r e  s e e n  i n  2 8  p a t i e n t s   














Table  4 .1  Per inea l  d i s ease s  and  HIV in fec t i v i ty  
 
Diseases HIV+ve                     
n                      % 
HIV –ve                      
n                        % 
    P Total                          























25                   10.4 
 
27                   11.2 
 
22                     9.1 
 
11                     4.6 
 
25                    10.4 
 
3                       1.2 
 
-                         - 
 
-                         - 
 
1                        0.4 
 
 
(13)                     
(13) 
 
37                    15.4 
 
40                    16.6 
 
2                       0.8 
 
35                   14.5 
 
34                    14.1 
 
1                       0.4 
 
3                       1.2 
 
2                       0.8 
 
1                      0.4 
 
 


























62                   25.8 
 
67                   27.8 
 
24                    9.9 
 
46                   19.1 
 
59                   24.5 
 
4                      1.6 
 
3                      1.2 
 
2                       0.8 
 
2                       0.8 
 
 









241                   100 
 
 











 4 . 1  Haemorrho ids  
 
4 . 1 . 1  D e m o g r a p h y :  
O n e  q u a r t e r  o f  b o t h  H I V  p o s i t i ve  an d  H I V  n e g a t i ve  p a t i e n t s  
( 2 5 / 1 0 0  a n d  3 7 / 1 4 1 ;  p = 0 . 4 )  p r e s e n t ed  w i t h  h a e mo r r h o i d s  ( T a b l e  
4 . 1 ) .  Nea r ly  ha l f  o f  a l l  t h e  pa t i e n t s  w i t h  h a e mo r r h o i d s  w e r e  
HIV  nega t i ve  ma le s  ( 29 /62 ) .  Ho w e v e r ,  t h e  p r o p o r t i o n  o f  me n  
a n d  w o m e n  w e r e  s i mi l a r  i n  H I V  p o s i t i v e  p a t i e n t s  ( T a b l e  4 . 2 ) .  
 
4 . 1 . 2  P re sen t a t i on  
4 . 1 . 2 . 1  S y mpt o ms  
T h e  ma i n  p r e s e n t i n g  s y mp t o ms  o f  h a e mo r r h o i d s  w e r e  a  ma s s  i n  
t w e l v e  HI V  n e g a t i v e  p a t i e n t s  a n d  sev e n  H I V  p o s i t i ve  p a t i e n t s  
( 1 2 / 3 7  v s  7 / 2 5 ;  p = 0 . 7 ) ,  p r o c t a lg i a  i n  s even  HIV  nega t i ve  
p a t i e n t s  a n d  o n e  H I V  p o s i t i v e  p a t i e n t  ( p < 0 .0 0 1 ) ,  b l e e d i n g  i n  
n ine  HIV  nega t i ve  and  t en  H I V  p o s i t i ve  p a t i e n t s  ( 9 / 3 7  v s  











T a b l e  4 . 2  P a t i e n t s  p r e s e n t i n g  wi t h  h a e m o r r h o i d s ,  b y  H I V  
s t a t u s  a nd  g e n d e r  
 
HIV Male                               
n                         % 
Female                            
n                             %     
Total                               
n                             % 
Negative 29                      47         8                          13  37                        60 
 
7                                   
2                                   
6 
6                                   
2                                    
2   
13                              
4                                   
8                             
Stage II 
Stage III                    
Stage IV 
Total  +ve 15                       24          10                         16        25                         40 
 44 18 62                         100 
 
 
 ( P e r c e n t a g e s  e x p r e s s  t h e  f r a c t i o n  o f  t h e  e n t i r e  s a m p l e  o f  p a t i e n t s  w i t h  
h a e m o r r h o i d s )  
                                          
 
T a b l e  4 . 3  S y m p t o m s  o f  h a e m o r r h o i d s   
 
HIIV Mass Proctalgia Bleeding Sepsis Pruritis ani Incontinence 





6                   
-                    
1 
-                    
-                    
1 
3                   
4                   
3 
2                    
-                    
- 
-                    
-                    
- 
-                     

















 4 . 1 . 2 . 2  P a s t  me d i c a l  a n d  s o c i a l  h i s t o r y   
A  h i g h e r  p r o p o r t i on  o f  H I V  p o s i t i ve  p a t i e n t s  w i t h  h a e m o r r h o i ds  
had  a  p r ev ious  h i s t o ry  o f  ha e mor rho id s  (11 /37  v s  12 /25 ;  
p=0 .07 )  and  o f  ana l  r e cep t i ve  i n t e r cou r se  (1 /37  v s  4 /25 ;  
p=0 .08 )  (Tab l e  4 . 4 ) .  
 
4 . 1 . 2 . 3  Phys i ca l  s i gns   
P r o l a p s e d  h a e mo r r h o i d s  w e r e  a  c o m m o n  f i n d i n g  i n  b o t h  H I V  
p o s i t i ve  a n d  n e g a t i v e  p a t i e n t s  ( 1 2 / 3 7  v s  7 / 2 5 ;  p = 0 . 7 ) .   
N i n e  H I V  p o s i t i v e  p a t i e n t s  h a d  a b n or ma l l y  w e a k  a n a l  t o n e  a n d  
e i g h t  o f  t h e m w e r e  a t  a d v a n c e d  H I V  s t a g e s ,  I I I  a n d  I V.  We a k  
a n a l  t o ne  w a s  a  co m mo n  f i n d i n g  i n  H I V  p o s i t i v e  p a t i en t s  w i t h  
h a e mo r r h o i d s  ( T a b l e  4 . 5 ) .  
 
4 . 1 . 2 . 4  I n v e s t i g a t i o n s  
4 . 1 . 2 . 4 . 1  B i o c h e mi s t r y  
T w o  H I V  n e g a t i v e  p a t i e n t s  a n d  t h r e e  H I V  p o s i t i ve  p a t i e n t s  h a d  
a  h a e mo g l o b i n  l e s s  t h a n  8 g / d l .  One  HIV  nega t i ve  pa t i en t  was  
d i a b e t i c .   T w o  H I V  p o s i t i ve  p a t i e n t s  h a d  l o w  a l b u mi n ,  l e s s  t ha n  
2 0 g / l ,  a nd  h i g h  u r e a ,  mo r e  t h a n  8  m m o l / l .  O n l y  o n e  H I V  












BOH STD Anal intercourse 





3                             
4                             
5 
-                               
-                              
- 
-                             
1                             
- 
3                             





B  O  H :  B a d  O b s t e t r i c  H i s t o r y  
S  T  D :  S e x u a l l y  T r a n s m i t t e d  D i s e a s e s  
 
               
 
T a b l e  4 . 5   A b n o r m a l  p h y s i c a l  s i g n s  o f  t h e  p a t i e n t s  wi t h  




High                                
anal tone 
Low                                 
anal tone 
Negative (N=37) 12 - - 
 
Stage II (N=13) 
Stage III (N=4) 
Stage IV (N=8) 
6                                      
-                                      
1 
1                                      
-                                       
- 
1                                       







T a b l e  4 . 6   T r e a t m e n t  o f  h a e m o r r h o i d s  
HIV Conservative                    RBL                                   Surgery  
                                           
Negative (N=37) 5                           5                               27                            
 
Stage II (N=13) 
Stage III (N=4) 
Stage IV (N=8) 
2                                     
-                                     
2                              
3                                    
2                                     
1                                 
8                                    
2                                     
5                               
 
 
                                        







 4 . 1 . 3  T r e a t me n t  a n d  i t s  o u t c o me  
E v e r y  p a t i e n t  w a s  i n i t i a l l y  o f f e r e d  c o n s e r v a t i v e  t r e a t m e n t  w i t h  
l axa t i ve s ,  t op i ca l  app l i c a t i on  such  a s  Anuso l®  o in tmen t  and  
l o c a l  a p p l i c a t i o n  o f  i c e  p a ck s .  
Rega rd l e s s  o f  HIV  s t a tu s ,  t hose  pa t i en t s  no t  r e spond ing  t o  t he  
c o n s e r v a t i v e  t r e a t me n t  u n d e r w e n t  e i t he r  r ubbe r  band  l i ga t i on  
( R B L )  f o r  G r a d e  I  a n d  I I  ha e mor r h o i d s  o r  h a e mo r r h o i d e c t o m y  
f o r  G r a d e  I I I  a n d  I V  h a e mo r r h o i d s .  I n  t h i s  s t ud y ,  n i n e  p a t i e n t s  
w e r e  t r e a t e d  c o n s e r v a t i v e l y ,  e l even  w i th  RBL,  and  fo r t y - two  
w i t h  h a e m o r r h o i d e c t o my .  A s  c a n  b e  s e e n  f r o m T a b l e  4 . 6 ,  
s i mi l a r  p r o p o r t i o ns  o f  b o t h  H I V  n e g a t i v e  a n d  p o s i t i v e  p a t i e n t s  
r e c e i v e d  e a c h  o f  t h e  t h r ee  o p t i o n s  o f  t r e a t me n t .  
H e a l i n g  a f t e r  h a e mo r r h o i d e c tomy  was  more  r ap id  i n  HIV  
n e g a t i ve  t h a n  H I V  p o s i t i v e  p a t i e n t s .  T h e  ma j o r i t y  he a l ed  i n  l e s s  
t han  t h r ee  weeks  (19 /27  HIV  –ve  v s  4 /15  HIV  +ve ,  p=0 .008 ) .  
A l l  H I V  p o s i t i ve  p a t i e n t s  w h o  h a d  h e a l e d  i n  t h r e e  w ee k s  w e r e  
a t  t h e  e a r l y  s t a g e  o f  H I V ,  s t a g e  I I .  N o  H I V  n e g a t i v e  p a t i e n t s  
t ook  l onge r  t han  s i x  weeks  fo r  hea l i ng ,  bu t  one  HIV  s t age  I I I  
pa t i e n t  and  t h r ee  HI V s t age  I V  pa t i en t s  d id  (0 /37  v s  4 /25 ;  




































                           
F i g u r e  4 . 2  H e a l i n g  v s  C D 4  c o u n t  a f t e r  h a e mo r r h o i d s  t r e a t me n t  
( T o t a l s  i n  F i g u r e  4 .2  a r e  n o t  t h e  s a me  a s  i n  F i gu r e  4 . 1  be c a u s e  




 A l t h o u g h  o n l y  a  s ma l l  n u m b e r  o f  pa t i en t s  ( n=17 )  had  CD4  
c o u n t s  m e a s u r e d ,  t h e  C D 4  c o u n t s  d id  n o t  a p p e a r  t o  p r ed i c t  t he  
h e a l i n g  t i me  a f t e r  h a e mo r r h o i d e c t o my .  A s  s h o w n  i n  F i g u r e  4 . 2 ,  
hea l i ng  t ook  l onge r  t han  s i x  w e e k s  i n  s i x  p a t i e n t s .  A mo n g  
t h e m,  o n e  h a d  a  C D 4  c o u n t  mo r e  t h a n  5 0 0 /μL  a n d  t h e  o t h e r  h a d  
a  C D 4  c o u n t  mo r e  t h a n  2 5 0 /μL.  
I n  o u r  e x p e r i e n c e ,  c o mp l i c a t i o n s  a f t e r  h a e m o r r h o i d  t r e a t me n t  
w e r e  i n f r e q u e n t  i n  b o t h  H I V  n e g a t i v e  ( o n e  p o s t - o p e r a t i v e  a n a l  
s t r i c t u r e )  a n d  p o s i t i v e  ( o ne  p o s t - o p e r a t i v e  f a e c a l  i n c o n t i n e n c e )  
p a t i e n t s .  B o t h  o f  t h e m w e r e  t r e a t e d  c o n s e r v a t i v e l y .  T h e r e  w e r e  
n o  s e p t i c  c o mp l i c a t i o n s  a f t e r  h a e mo r r h o i d  t r e a t me n t  i n  t h i s  
s t u d y .  
 
4 . 1 . 4  D i s c u s s i o n  
I n  t h i s  s t u d y ,  2 5 %  o f  t h e  H I V  p o s i t i v e  p a t i e n t s  w i t h  
p r o c t o l o g i c a l  s y m p t o ms  h a d  h aemor rho id s .  Th i s  f i nd ing  i s  
c o n s i s t e n t  w i t h  t h e  l i t e r a tu r e  wh ich  r epo r t s  6 -18% 
occu r r ence . 5 , 1 5 - 1 7  I t  w a s  n o t  d i f f e r e n t  f r o m  H I V  n e g a t i v e  
p a t i e n t s  i n  o u r  e x p e r i e nce  (25 /100  v s  37 /141 ;  p=0 .8 ) .  
B o t h  H I V  p o s i t i v e  a n d  n e g a t i v e  p a t i en t s  h a d  t y p i c a l  p re s e n t i n g  





 A l t h o u g h  i t  h a s  n o t  b e e n  p r e v i o u s l y  de sc r i bed  i n  t he  l i t e r a tu r e ,  
H I V  n e g a t i v e  p a t i e n t s  h a d  m o r e  pa in  (7 /37  v s  1 /25 ;  p=0 .087 )  
a n d  H I V  p o s i t i v e  p a t i e n t s  h a d  mor e  b l e e d i ng  ( 9 / 3 7  v s  1 0 / 2 5 ;  
p = 0 . 1 )  i n  o u r  e x p e r i e n c e .  
Bo th  g roups  o f  pa t i en t s  had  p r e v i o u s  h a e mo r r h o i d a l  p r o b l e ms  
( 1 1 / 3 7  v s  1 0 / 2 5 ;  p = 0 . 4 0 ) .  M o r e  H I V  p o s i t i ve  p a t i e n t s  a d mi t t e d  
p r a c t i s i n g  a n a l  r e c e p t i v e - i n t e r cou r se  (1 /37  v s  4 /25 ;  p=0 .039 ) .   
M o r e  t h an  a  t h i r d  o f  H I V  p o s i t i ve  p a t i e n t s  ha d  w e a k  a n a l  t o n e ,  
bu t  none  o f  HIV  nega t i ve  pa t i en t s  h a d  ( 0 / 3 7  v s  9 / 2 5 ;  p = 0 . 0 0 1 ) .  
A l t h o u g h  n o t  a  d i a g n o s t i c  c r i t e r i a  o f  AIDS  a cco rd ing  t o  CDC 
c l a s s i f i c a t i o n , 4  t he  ma j o r i t y  o f  s t a g e  I V  H I V  p a t i en t s  w i t h  
h a e mo r r h o i d s  ( 6 / 8 )  h a d  a b n o r ma l l y  weak  ana l  t one  (Tab l e  4 . 5 ) .  
I n  t he  l i t e r a tu r e ,  immune  de f i c i e n t  p a t i e n t s  a r e  r e p o r t e d  t o  b e  
m o r e  s u sc e p t i b l e  t o  s e r i o us  c o mpl i c a t i o ns ,  s u c h  a s  s e p s i s  a n d  
d e l a y e d  h e a l i n g ,  a f t e r  t r e a t me n t  f o r  h a e mo r r h o i d s . 1 7 - 1 9  F o r  t h i s  
r e a son ,  eve ry  HIV  pos i t i ve  pa t i en t  was  o f f e r ed  conse rva t i ve  
t r e a t me n t  i n i t i a l l y .  H o w e v e r ,  f a i l u r e  o f  c o n s e r v a t i v e  
ma n a g e m e n t  a n d  t h e  p a t i e n t ’ s  r e q u es t  fo r  d e f i n i t i v e  t r e a t me n t  
l e d  t o  mo r e  i n v a s i v e  t r e a t me n t s ,  r u b b e r  b a n d  l i g a t i o n  i n  s i x  
p a t i e n t s  a n d  h a e mo r r h o i d e c t o my  i n  f i f t e en  pa t i en t s .  I nd i ca t i o ns  
fo r  t h e s e  p r o c e d ur e s  w e r e  s i mi l a r  i n  b o t h  H I V  p o s i t i v e  a n d  




 A s  me n t i o n e d  a b o v e ,  p o s t - h a e mo r r h o i d e c t o my  c o mpl i c a t i o n s  
w e r e  i n f r e q u e n t  i n  o u r  e x p e r i e n c e .  N o  p a t i e n t s  h a d  p o s t -
o p e r a t i v e  s e p t i c  c o mpl i c a t i o n s ,  i n  c o n t r a s t  t o  r e p o r t s  i n  t h e  
l i t e r a t u r e . 7 , 1 8 , 1 9   
A c c o r d i ng  t o  M o or e  e t  a l , 2  r ubbe r  band  l i ga t i on  can  be  s a f e ly  
p e r f o r me d  i n  s e l e c t e d  H I V p o s i t i v e  p a t i e n t s .  H o w e v e r ,  n o n e  o f  
h i s  e l e v e n  p a t i e n t s  h a d  A I D S .  E n c o u r a g i n g  o u t c o m e s  a f t e r  
ano rec t a l  su rge ry ,  i nc lud ing  haemor rho idec tomy ,  a ga in  i n  
s e r o p o s i t i v e  p a t i e n t s  w h o  d i d  n o t  h a v e  A I D S ,  w e r e  d e s c r i b e d  b y  
S a f v i . 8   
I n  ou r  s t udy ,  s i x  pa t i en t s  w i th  AIDS  had  haemor rho id  
t r e a t me n t s  ( o n e  h a d  r u b b e r  b a n d  l i g a t i o n  a n d  t h e  o t h e r s  h a d  
h a e mo r r h o i d e c t o my ) .  I t  i s  p r o b a b l e  t h a t  t h e  a b s e n c e  o f  s e p t i c  
c o mp l i c a t i o n s  w a s  r e l a t e d  t o  t h e  u s a g e  o f  p e r i - o p e r a t i v e  
a n t i b i o t i c s  a s  w e l l  a s  a n t i - r e t r o v i r a l  t h e r a p y  fo r  t h e  p a t i e n t s  
w i t h  a d v a n c e d  H I V  s t a g e .   
A l t h o u g h  t h e r e  we r e  n o  s e p t i c  compl i ca t i ons ,  HIV  pos i t i ve  
pa t i en t s  d id  have  de l ayed  w o u n d  h e a l i n g .  A l l  p a t i e n t s  w i t h  
d e l a y e d  w o u n d  h e a l i n g  mor e  t h a n  s i x  w e e k s  w e r e  a d v a n c e d  
s t a g e  H IV - p o s i t i ve  p a t i e n t s .  I n  t h i s  r e s p ec t ,  w e  a g r e e  w i t h  t he  
r e p o r t  by  M o r a nd i 1 9  o f  a  h igh  i nc idenc e  o f  de l ayed  wound  





The  CD4  coun t  was  no t  a  good  p r ed i c to r  f o r  wound  hea l i ng  
a f t e r  h a e m o r r h o i d e c t o my  i n  t h i s  s t udy ,  and  t h i s  f i nd ing  i s  






















 4 . 2  F i s t u l a  i n  a n o  
 
4 . 2 . 1  Demography  
N e a r l y  one  t h i r d  o f  b o t h  H I V  p o s i t i v e  a n d  n e g a t i ve  p a t i e n t s  
p r e sen t ed  w i th  f i s t u l a s .  As  s h o w n  i n  T a b l e  4 . 7 ,  a n a l  f i s t u l a s  
w e r e  mor e  c o m m o n  i n  ma l e s  i n  o u r  e x p e r i e n c e ,  ( ma l e :  f e ma l e  
r a t i o  a p p r o x i ma t e l y  3 : 1  i n  b o t h  + v e  a n d  – v e  p a t i e n t s ) ,  
cons i s t en t  w i th  t he  gene ra l  t endency  i n  t h i s  d i s ea se .  
  
4 . 2 . 2  P re sen t a t i on  
4 . 2 . 2 . 1  S y mpt o ms  
T h e  ma i n  p r e s e n t i n g  s y mpt o ms  w e r e  s ma l l  n o d u l e s ,  i n  f i v e  H I V  
n e g a t i ve  a n d  s i x t e e n  H I V  p o s i t i ve  p a t i e n t s  ( 5 / 4 0  vs  1 6 / 2 7 ;  
p = 0 . 0 0 0 1 ) ;  p a i n ,  i n  f i v e  H I V  n e g a t i v e  a n d  s e v e n t e e n  H I V  
p o s i t i ve  p a t i e n t s  ( 5 / 4 0  v s  1 7 / 2 7 ;  p= 0 . 0 0 0 1 ) ;  d i s c h a r ge ,  i n  t h e  
ma jo r i t y  o f  pa t i en t s  ( 38 /40  v s  25 /27 ;  p=0 .65 ) ;  and  
i n c o n t i n en c e ,  i n  s ix t e e n  H IV  p o s i t i ve  p a t i e n t s .  N o n e  o f  t h e  H I V  
n e g a t i ve  p a t i e n t s  p r e s e n t e d  w i t h  i ncon t i nence  (0 /40  v s  16 /27 ;  












T a b l e  4 . 7  G e n d e r  a n d  H I V  s t a t u s  o f  pa t i en t s  wi th  ana l  
f i s t u l a  
  
HIV Male                       % Female                  % Total 
Negative 32                          80 8                            20 40 
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Total +ve 20                         74.1 7                             25.9 27 








T a b l e  4 . 8  S y m p t o m s  o f  a na l  f i s t u l a                   
                                      
HIV Nodule Proctalgia Discharge Incontinence 
Negative (N=40) 5 5 38 
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Stage II (N=5) 
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 4 . 2 . 2 . 2  Pa s t  h i s t o ry   
E igh t  HIV  nega t i ve  (8 /40 )  and  twe lve  HIV  pos i t i ve  (12 /27 )  
p a t i e n t s  w i t h  f i s t u l a  g a v e  a  h i s t o ry  o f  p r ev ious  absce s s  
( p=0 .032 ) .  No  pa t i en t s  had  a  p r i o r  obs t e t r i c  p rob l em o r  any  
s e x u a l l y  t r a n s mi t t e d  d i s e a se s  ( S T D) ,  o r  p r a c t i s e d  a n a l  r e c e p t i v e  
i n t e r c o u r s e .  
 
4 . 2 . 2 . 3  Phys i ca l  s i gns  
A n a l  f i s t u l a s  w e r e  c l a s s i f i e d  d e p e n d i n g  o n  t h e  c o u r s e  o f  t h e  
f i s t u l a  t r a c t  i n  r e l a t i o n  t o  t h e  a n a l  s p h i n c t e r s  ( F i g u r e  4 . 3 ) :  
I n t e r - s p h i n c t e r i c :  t h e  t r a c t  p a s s e s  b e t w e e n  t h e  i n t e r n a l  a n d  
e x t e r na l  a n a l  s p h in c t e r s  
T r a n s - s ph i n c t e r i c :  t h e  t r a c t  p a s s e s  t h r o u g h  t h e  e x t e r n a l  a n a l  
sph inc t e r  
S u p r a - s p h i n c t e r i c :  t h e  t r a c t  p a s s e s  a b o v e  t h e  e x t e r n a l  a n a l  
sph inc t e r  
E x t r a - s p h i n c t e r i c :  t h e  t r a c t  p a s s e s  t h r o u g h  t h e  e n t i r e  s p h i n c t e r  
me c h a n i s m  w i t h  a  s u p r a l e va t o r  i n t e r na l  o p e n i ng  
Complex :  a  f i s t u l a  w i th  a  s econda ry  t r a c t  a n d / o r  t r a c t  c o u r s e  
a r o u n d  m o r e  t h a n  h a l f  o f  t h e  c i r cumfe rence  o f  t he  ex t e rna l  
sph inc t e r  
M u l t i p l e :  M u l t i p l e  f i s t u l a s ,  p r e s e n t i ng  mor e  t ha n  t w o  f i s t u l a s  





               
 
  I n t e r - s p h i n c t e r i c  f i s t u l a                   T r a n s - s p h i n c t e r i c  f i s t u l a   
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S u p r a - s p h i n c t e r i c  f i s t u l a                      E x t r a - s p h i n c t e r i c  f i s u l a  
 






4 . 2 . 2 . 4  I n v e s t i g a t i o n s  
4 . 2 . 2 . 4 . 1  B i o c h e mi s t r y  
Th i r t e en  pa t i en t s  w i th  f i s t u l a s  h a d  a b n o r ma l  b l o o d  
b i o c h e mi s t r y .  T w o  H I V  n e g a t i v e  a n d  fo u r  H I V  p o s i t i ve  p a t i e n t s  
h a d  l o w  a l b u mi n ,  l e s s  t h a n  2 0 g / l .  O n e  H I V  n e g a t i v e  p a t i e n t  w a s  
d i abe t i c .  Th ree  HIV  pos i t i ve  pa t i e n t s  a t  s t a g e  I V  h a d  l o w  
h a e mo g l o b i n  ( l e s s  t h a n  8 g / d l ) ,  a n d  h i g h  u r e a  ( mo r e  t h a n  8  
m m o l / l ) .  
 
4 . 2 . 2 . 4 . 2  H i s to logy  
T h e  h i s t o l o g y  o f  f i s t u l a s  wa s  r e q u es t ed  i n  29  ca se s  e spec i a l l y  
i n  p a t i e n t s  w i t h  co mpl e x  o r  mu l t i p l e  f i s t u l a s .  M o s t  o f  t h e m  
showed  non - spec i f i c  h i s t o logy .  Howeve r ,  two  HIV nega t i ve  
p a t i e n t s  w i t h  l o ng  s t a n d i ng  f i s t u l a  h a d  ma l i g n a n t  l e s i o n s  a n d  
t w o  H I V  p o s i t i v e  p a t i e n t s  w i t h  m u l t i p l e  f i s t u l a s  ha d  t h e  
g r a n u l o ma t o u s  h i s t o l o g y  s u g g e s t i v e  o f  t u b e r c u l o s i s  
( T a b l e  4 . 1 0 ) .  
 
4 . 2 . 3  T r e a t me n t  a n d  i t s  o u t c o me  
T r e a t me n t  w a s  d e t e r mi n e d  i n d i v i d u a l l y ,  d e p e n d i n g  o n  t h e  t y p e  




 F i s t u lo tomy ,  l ay ing  open  o f  t he  f i s t u l a  t r a c t ,  w a s  u s e d  f o r  l o w  
f i s t u l a s ,  w h e r e  t he  i n t e r n a l  o p en i n g  w a s  b e l ow  t h e  l e ve l  o f  t h e  
d e n t a t e  l i n e .  
A  s e t o n  s t i t c h  ( u sua l l y  a  s i l i c one  f eed ing  t ube ,  5F  t o  8F )  wa s  
u s e d  f o r  t h e  h i g h  f i s t u l a s  wh e r e  t h e  i n t e r n a l  o p e n i n g  wa s  a b o v e  
t h e  d e n t a t e  l i n e .  
C o l o s t o m y  w a s  u s e d  f o r  mu l t i p l e  f i s t u l a s  w i t h  s e v e r e  i n f e c t i o n .  
E a c h  p a t i e n t  r e c e i v e d  p r o ph y l a c t i c  i n t r a v e n ous  a n t i b i o t i c s ,  1 . 2  
g m o f  A u g me n t i n ® .  I n  s e v e r e  se p s i s ,  t he  a n t i b i o t i c  w a s  
c o n t i n u e d  i f  n e c e s sa r y .   
P a t i e n t s  w e r e  r e v i e w e d  a t  t wo  w e e k l y  i n t e r v a l s  a f t e r  t he  
p r o c e d u r e  u n t i l  h e a l i n g .  Se t o n  s t i t che s  we re  t i gh t ened  a t  t he  
s a me  t i m e  u n t i l  t h e y  c u t  t h rough  t he  f i s t u l a s .  Hea l i ng  was  
r e c o r de d  w h e n  t h e  p a t i e n t  b e c a me  p a i n  f r e e ,  t h e r e  w a s  n o  mor e  
r ec t a l  b l eed ing ,  no  d i s cha rge  an d  n o  t e n d e r n e s s  a t  t h e  s u r g i c a l  
wound .   
T h e  F i g u r e s  4 . 4 ,  4 . 5  a n d  4 . 6  s h o w  t h a t  t h e  h e a l i n g  t i m e  w a s  n o t  
d e t e r mi n e d  b y  H I V  s t a t u s  a n d  C D 4 ,  b u t  b y  t h e  t y p e s  o f  f i s t u l a s ,  
i n  w h i c h  c o mpl e x  f i s t u l a s  a n d  t r a n s - s p h i n c t e r i c  f i s t u l a s  n e e d e d  
a  l o n g e r  h e a l i n g  t i me .  F o u r t e e n  HIV  nega t i ve  pa t i en t s  had  a  
h e a l i n g  t i me  l o n g e r  t h a n  s i x  w e e k s .  T e n  H I V  n e g a t i v e  p a t i e n t s  
w i t h  c o m p l e x  f i s t u l a s  a n d  s e v e n  p a t i e n t s  ( 4  – v e  a n d  3  + v e )  w i t h  




























































Figu re  4 .6  Hea l i ng  v s  t ype  o f  f i s t u l a  
I . S :  I n t e r s p h i n c t e r i c  
T . S :  T r a n s s p h i n c t e r i c  
S . S :  S u p r a s p h i n c t e r i c  
RVF:  Rec t ovag ina l  
 
Fou r  pa t i en t s  w i th  AIDS  d i ed  du r i n g  fo l l o w - up  a s  t h e  r e s u l t  o f  
t h e i r  p o o r  g e n e r a l  c o n d i t i on .  O n e  H I V  n e g a t i v e  p a t i e n t  h a d  
p o s t - o p e ra t i v e  f a ec a l  i n c o n t i n e n ce  a f t e r  f i s t u l o t o my ,  w h i c h  w a s  














Recto-vaginal Multiple Complex 
Negative 16 9 1 
 
- 1 12 
2                     
8                     
3                    
3                        
2                        
1                       
-                        
-                        
-                       
-                         
-                         
1                       
-               
2              
5 
-               





Total  +ve  13                   6                          -                        1                        7 1 






T a b l e  4 . 1 0  H i s t o l o g y  o f  f i s t u l a s  
HIV Non-specific TB Malignant 





1                                        
2                                       
6 
1                                        
-                                        
1 
-                                       








T a b l e  4 . 1 1  T r e a t m e n t  o f  f i s t u l a s  
 
HIV Fistulotomy Seton stitch Colostomy  
Negative 21 19 - 
 
40 
3                                 
7                                 
2 
4                                
4                                
2 
-                             
-                             
5 
 Stage II 
Stage III 
Stage IV 






4 . 2 . 4  D i s c u s s i o n  
N e a r l y  one  t h i r d  o f  t h e  p a t i e n t s  i n  t h i s  s t ud y  p r e s en t e d  w i t h  
a n a l  f i s t u l a s .   
I n  t he  l i t e r a tu r e ,  i t  h a s  been  r ep or t e d  t h a t  a n a l  f i s t u l a s  a r e  
c o m m o n l y  s e e n  i n  H I V  p o s i t i ve  i n d i v i d u a l s . 2 0 , 2 1  A l t h o u g h  s o me  
a s p e c t s  o f  a n a l  f i s t u l a s  h a v e  b e e n  e x a mi n e d ,  n o t  mu c h  i s  k n o w n  
a b o u t  a n a l  f i s t u l a s  i n  H I V  p o s i t i ve  p a t i e n t s .   
A c c o r d i n g  t o  M a n o o k i a n ,  H I V  s t a t u s  i n f l uences  t he  ana tomy  o f  
a n a l  f i s t u l a s  a n d  H I V  p o s i t i v e  p a t i e n t s  w e r e  m o r e  l i k e l y  t o  h a v e  
i n c o mp l e t e  a na l  f i s t u l a s  (b l i n d  t r ac t s ,  s i n us e s )  t h a n  o t h e r s .  
H o w e v e r ,  t h e i r  s ym p t o ms  a r e  s i mi l a r  i n  b o t h  H I V  p o s i t i ve  a n d  
n e g a t i v e  p a t i e n t s . 2 1   
I n  o u r  ex p e r i e nc e ,  b o t h  HI V  n e g a t i v e  a n d  p o s i t i ve  p a t i e n t s  
p r e sen t ed  w i th  s im i l a r  symp toms  o f  pe r i nea l  nodu l e s ,  pa in  and  
d i s c h a r ge .  H o w e v e r ,  mor e  t h a n  h a l f  o f  H I V  p o s i t i ve  p a t i e n t s  
p r e s e n t e d  w i t h  a na l  i n c o n t i n e n c e  an d  a l l  o f  t h e m w e r e  i n  t he  
a d v a n c e d  s t a g e s  o f  H I V ,  e i t h e r  a t  s t age  I I I  o r  I V .   
Conce rn ing  t ypes  o f  f i s t u l a s ,  b o t h  g r o u p s  h a d  a l mos t  s i mi l a r  
p r e s e n t a t i o n s  o f  s i mp l e  f i s t u l a s .  Howeve r ,  HIV nega t i ve  
p a t i e n t s  h a d  mor e  c o mpl e x  f i s t u l a s  ( 1 2 / 4 0  H I V  n e g a t i v e  v s  1 / 2 7  




 m u l t i p l e  f i s t u l a s  (7 / 2 7  H I V  p o s i t i v e  v s  1 / 4 0  H I V  n e g a t i ve ,  
p = 0 . 0 0 6 )  ( T a b l e  4 . 9 ) .  O n e  p o s s i b l e  r e a s o n  f o r  u n e x p e c t e d l y  
l a rge  number s  o f  comp lex  f i s t u l a s  i n  t he  pa t i en t s  w i thou t  HIV  
ma y  b e  b e c a u s e  o f  a  r e f e r r a l  b i a s  t o  a  s p e c i a l i s e d  c o l o r e c t a l  
s e r v i c e .   
N e a r l y  a  q u a r t e r  (6 / 2 5 )  o f  H I V  p o s i t i v e  p a t i en t s  h a d  l o w  a n a l  
t o n e  a n d  m o s t  o f  t h e m w e r e  a t  s t a g e  I V .  
A l t h o u g h  t h e  ma j o r i t y  o f  b i o p s y  r e s u l t s  w e r e  n o n - s p e c i f i c  
( 1 6 / 1 8  H I V  n e g a t i v e  a n d  9 / 1 1  H I V  p o s i t i ve ) ,  t w o  H I V  p o s i t i ve  
pa t i en t s ’  b iops i e s  showed  myc o b a c t e r i u m i n f e c t i o n  ( T B )  a n d  
two  o f  HIV  nega t i ve  pa t i en t s ’  s h o w e d  ma l i g n a n t  p a t h o l o g y .  
T h i s  d i a g n o s i s  w a s  n o t  c o n s i d e r e d  o n  c l i n i c a l  g r o u n d s  p r i o r  t o  
t h e  h i s t o l o g i c a l  r e p o r t .  A l t h o u g h  t h i s  i s  o n l y  a  s ma l l  s a mp l e  
( e l e ve n  H I V  p o s i t i v e  p a t i e n t s ) ,  i t  i s  p o s s i b l e  t h a t  t ub e r c u l o us  
f i s t u l a s  a r e  n o t  u n c o m m o n  an d  w e  p r o p o s e  s e n d i n g  t i s s u e  f o r  
h i s t o l o g i c a l  e x a mi n a t i o n  r o u t i n e l y .   
N a d a l  e t  a l  s t u d i e d  h e a l i n g  a f t e r  a n a l  f i s t u l o t o my .  T h e y  
c o n c l u d e d  t h a t  H I V  p o s i t i v e  pa t i en t s  w i th  l ow  CD4  coun t s  
s h o u l d  h a v e  s u r g i c a l  t r e a t me n t  o n ly  i n  e me r g e n c y  c a s e s ,  a s  t h e y  
t e n d  t o  h a v e  p o s t - o p e r a t i v e  c o mpl i ca t i o n s .  T h o s e  p a t i e n t s  i n  t h e  
e a r l i e r  H I V  s t a g e  s h o u l d  h a v e  t h e  s a m e  s u r g e r y  a s  H I V  n e g a t i v e  
p a t i e n t s . 2 2  
I n  ou r  expe r i ence ,  hea l i ng  a f t e r  t he  t r e a t me n t  o f  f i s t u l a s  w a s  
n o t  d e t e r mi n e d  b y  t h e  H I V  s t a t u s  o f  pa t i en t s ,  bu t  r a t he r  by  t he   
 29
  
t ype s  o f  f i s t u l a s .  Those  t ha t  ha d  hea l i ng  t imes  l onge r  t han  s i x  
w e e k s  w e r e  mo s t l y  H I V  n e g a t i v e  p a t i e n t s  ( F i g u r e  4 . 4 ) .   
C D 4  c o u n t s  w e r e  n o t  a  g o o d  i n d i c a t o r  f o r  h e a l i n g  t i me ,  a s  a  
n u mbe r  o f  p a t i e n t s  w i t h  r e a s o n a b l e  C D 4  c o u n t s  h a d  l o n g e r  
h e a l i n g  t i me s  ( F i g u r e  4 . 5 ) .    
H o w e v e r ,  i t  w a s  t h e  t y pe s  o f  f i s t u l a s  t ha t  d e t e rmi n e d  t h e  
h e a l i n g  t i me .  T r a n s - s p h i n c t e r i c  f i s t u l a s  a n d  c o mpl e x  f i s t u l a s  
n e e d e d  l o n g e r  t o  h e a l .  I n t e r - s p h i n c t e r i c  f i s tu l a s  hea l ed  f a s t e r  
( F i g u r e  4 . 6 ) .  I n  c o n t r a s t  t o  t h e  c o n c e r n s  i n  t h e  l i t e r a t u re , 2 2  
s e p t i c  c o m p l i c a t i o n s  w e r e  n o t  a  p r o b l e m i n  o u r  e x p e r i e n c e .  
U s i n g  p r o p h y l a c t i c  a n t i b i o t i c s  an d  d r a i n i n g  s e t o n  s u t u r e s  mi g h t  
a c c o u n t  f o r  t h i s .  H o w e v e r ,  f o u r  H I V  p o s i t i v e  pa t i e n t s  d i e d  
d u r i n g  t h e  c o u r s e  o f  f o l l o w - u p .  A l l  o f  t h e m w e r e  i n  s t a g e  I V  
H I V  a n d  p r e s e n t ed  w i t h  m u l t i p l e  f i s t u l a s ;  t h e y  w e re  t r ea t e d  
w i t h  d i v e r t i n g  c o l o s t o my .   
I n  o u r  e x p e r i e n c e ,  t h e  i n d i v i d u a l s  i n  t h e  s t a g e  I V ,  p r e s e n t i n g  
w i t h  mu l t i p l e  f i s t u l a s  h a d  a  v e r y  p o o r  p r o g n o s i s ;  h o w e v e r  t h e i r  
d e a t h s  we r e  r e l a t e d  t o  t he  a d v a n c e d  s t a g e  o f  t h e i r  d i s e a se ,  






4 . 3  A n a l  U l c e r  a n d  f i s s u r e   
 
4 . 3 . 1  Demography  
I n  t h i s  s e r i e s ,  2 4  p a t i e n t s  ( 1 4  ma l e s  a n d  1 0  f e ma l e s )  h a d  a n a l  
u l c e r s  a n d  4 6  p a t i e n t s  ( 1 9  ma l e s  a n d  2 7  f e ma l e s )  h a d  a n a l  
f i s s u r e s .  I n  g e n e r a l ,  H I V  n e g a t i v e  pa t i en t s  we re  o lde r  t han  HIV  
p o s i t i ve  p a t i e n t s  ( T a b l e s  4 .1 2  a n d  4 . 1 3 ) .  
 
4 . 3 . 2  P re sen t a t i on  
4 . 3 . 2 . 1  S y mpt o ms  
Bo th  ana l  u l ce r s  and  f i s su r e s  h a d  s imi l a r  p r e s e n t i n g  sy mp t o ms  
o f  p roc t a lg i a ,  b l eed ing  and  i ncon t i nence  (Tab l e s  4 . 14  and  
4 .15 ) .  I n  ou r  expe r i ence ,  i t  was  ve ry  d i f f i cu l t  t o  d i f f e r en t i a t e  
t he se  two  cond i t i ons  i n  t e rms  o f  t h e i r  s y mp t o ms  p a r t i c u l a r l y  i n  
HIV  in f ec t ed  i nd iv idua l s .  
 
4 . 3 . 2 . 2  P a s t  me d i c a l  a n d  s o c i a l  h i s t o r y  
A  h i s t o ry  o f  p roc t a lg i a  wa s  c o m m o n l y  r e p o r t e d .  F o u r  H I V  
p o s i t i ve  p a t i e n t s  w i t h  a n a l  u l c e r s  a n d  f i v e  H I V  n e g a t i ve  
p a t i e n t s  w i t h  a n a l  f i s s u r e s  a d mi t t e d  p r a c t i s i n g  a n a l  r e c e p t i v e  






4 .3 .2 .3  Phys i ca l  s i gns  
C a r e fu l  e x a mi n a t i o n  d i f f e r e n t i a t e s  t he s e  t w o  c o n fu s i n g  
pa tho log i e s .  
S e n t i n e l  p i l e s  w e re  p r e s e n t  i n  t h i r t y  p a t i e n t s  w i t h  a n a l  f i s s u r e s  
( 3 0 / 4 6 ) ,  b u t  n o n e  i n  p a t i e n t s  w i t h  a n a l  u l c e r s  ( p < 0 . 0 0 0 1 ) .   
A b n o r ma l l y  w e a k  a n a l  t o n e  w a s  d e t ec t ed  i n  t he  ma jo r i t y  o f  ana l  
u l c e r s  i n  H I V  p o s i t i ve  p a t i e n t s  ( 13 /2 2 ) ,  b u t  o n l y  o n e  s t a g e  I V  
H I V  p a t i e n t  w i t h  a n a l  f i s s u r e  h a d  a  w e a k  a n a l  t on e  ( 1 / 1 1 )  
( p < 0 . 0 0 1 ) .   T h e  m a j o r i t y  o f  a n a l  f i s su r e s  i n  bo t h  H I V  p o s i t i ve  
(8 /11 )  and  nega t i ve  (29 /35 )  ( p= 0 . 4 6 )  p a t i e n t s  h a d  a  h i g h e r  a n a l  
t one ,  bu t  none  o f  t he  pa t i en t s  w i t h  a n a l  u l c e r s  h a d  i n c r e a s e d  
t o n e  ( p < 0 . 0 0 0 1 )  ( Ta b l e s  4 . 1 8  a n d  4 . 1 9 ) .  
 
4 . 3 . 2 . 4  I n v e s t i g a t i o n s  
4 . 3 . 2 . 4 . 1  B i o c h e mi s t r y  
H I V  p o s i t i v e  p a t i e n t s ,  e s pe c i a l l y  i n  a d v a n ce d  s t a g es ,  h a d  a  
t e n d e n c y  t o  a b n o r ma l  b l o o d  b i o c he mi s t r y .  F i v e  H I V  p o s i t i ve  
p a t i e n t s  w i t h  a n a l  u l c e r s  a nd  o n e  H IV  p o s i t i ve  p a t i e n t  w i t h  a n a l  
f i s s u r e  h a d  l o w  a l b u mi n  ( l e s s  t h a n  20 g / l )  a n d  r a i s e d  u re a  ( mo r e  
t h a n  8  m m o l / l ) .  Two  H I V  n e g a t i ve  pa t i e n t s ,  one  w i t h  ana l  u l c e r  
a n d  t h e  o t h e r  w i t h  a n a l  f i s s u r e ,  w e r e  a n a e mi c ,  h a e mo g l o b i n  
l e v e l  l e s s  t h a n  8g / d l .  O ne  H I V  n e g a t i ve  p a t i e n t  w i t h  a n a l  




4 .3 .2 .4 .2  H i s to logy  
The  ma jo r i t y  o f  b iops i e s  we re  non- s p e c i f i c .  Ho w e v e r ,  b i o p s y  i s  
ma n d a t o r y  t o  e x c l u d e  o t h e r  p a t ho l o g i e s ,  s u c h  a s  T B  a n d  
ma l i g n a n c y .  O n e  H I V  n e g a t i v e  p a t i e n t  h a d  a  ma l i g n a n t  u l c e r  
a n d  t w o  H I V  p o s i t i v e  p a t i e n t s  h a d  t u b e r c u l ous  u l c e r s  ( T a b l e s  




T a b l e  4 . 1 2  A g e  a n d  H I V  s t a t u s  o f  pa t i e n t s  wi t h  a n a l  u l c e r   
HIV  n                    Age: median (range)  
Negative 2 64 y (52-76) 
 
3                                        
5                                  
14 
35 y (25-64)                       
34 y (32-36)                       










T a b l e  4 . 1 3  A g e  a n d  H I V  s t a t u s  o f  pa t i e n t s  wi t h  a n a l  f i s s u r e  
 
HIV  n                    Age: median (range)  
Negative 35 42 y (19-64) 
 
6                                        
3                                       
2 
32 y (23-64)                      
35 y (34-39)                       















T a b l e  4 . 1 4  S y m p t o m s  o f  a na l  u l c e r  
HIV n                Proctalgia Bleeding Incontinence 





3               
5                
14 
3                                 
5                                 
14 
-                            
2                           
3 
-                             







T a b l e  4 . 1 5  S y m p t o m s  o f  a na l  f i s s u r e  
HIV n                Proctalgia Bleeding Incontinence 
Negative 35 35 20 - 
 
6                
3                
2 
6                                
3                                 
2 
3                            
1                            
- 
-                             





















 T a b l e  4 . 1 6  P r e v i o u s  h i s t o r y  o f  p a t i e n t s  wi t h  a n a l  u l c e r  
                                  
HIV Previous proctalgia       BOH STD Anal intercourse 





1                                    
3                                    
10 
-                             
-                           
- 
-                       
-                      
- 
-                                       













T a b l e  4 . 1 7  P r e v i o u s  h i s t o r y  o f  p a t i e n t s  wi t h  a n a l  f i s s u r e  
 
HIV Previous proctalgia       BOH STD Anal intercourse 





4                                    
-                                    
1 
-                             
-                           
- 
1                      
-                      
- 
1                                     




































T a b l e  4 . 1 8  P h y s i c a l  s i g n s  o f  a n a l  u l c e r  
HIV Sentinel pile Anal mucosal defect                           
anterior     posterior       multiple 
Anal tone                          
high                   low 





-                      
-                     
- 
-                3                     -                  
-                5                     -                  
2               11                   1 
-                          1            
-                          2            









T a b l e  4 . 1 9  P h y s i c a l  s i g n s  o f  a n a l  f i s s u r e   
                      
                      
HIV Sentinel pile Anal mucosal defect                           
anterior     posterior       multiple 
Anal tone                          
high                   low 





4                      
-                     
- 
1                4                     1                  
1                2                     -                  
-                 2                     - 
6                          -            
2                          -           


































T a b l e  4 . 2 0  H i s t o l og y  o f  a n a l  u l c e r  
 
                           
HIV Non-specific TB Malignant CMV proctitis 





2                              
3                              
12 
1                              
1                              
- 
-                              
-                              
-   
-                             
-                              
1      










Table  4 .21  Hi s to logy  o f  ana l  f i s sure  
 
HIV Non-specific TB Malignant Bilharzia 





5                              
3                              
2 
-                              
-                              
- 
-                              
-                              
-   
-                             
-                              
-     





































T a b l e  4 . 2 2  T r e a t m e n t  o f  a na l  u l c e r  
 












-                              
3                              
6 
-                              
4                              
2 
2                             
-                              
-   
-                             
-                              
1     






T a b l e  4 . 2 3  T r e a t m e n t  o f  a na l  f i s s u r e  
 
                   












2                              
1                              
1 
-                              
-                              
- 
4                             
2                              
1   
-                             
-                              
-     



























4 . 3 . 3  T r e a t me n t  a n d  i t s  o u t c o me  
T r e a t me n t  s t a r t e d  w i t h  a n a l g e s i c s  a nd  l o c a l  g l y c e r y l  t r i n i t r a t e .  
E x a mi n a t i o n  u n d e r  a n a e s t he s i a  ( E U A )  w a s  pe r f o r me d  i n  e a c h  
p a t i e n t  a n d  t h e  t y p e  o f  s u r g i ca l  t r e a t me n t  w a s  d e t e r mi n e d  
a c c o r d i n g  t o  t h e  f i n d i n g s .  E a c h  p a t i e n t  r e ce i v e d  p r o ph y l a c t i c  
I V I  A u g me n t i n ®  1 . 2  g m.  O r a l  a n t i b i o t i c s  ( A u g me n t i n ®  6 2 5  m g  
t . d . s )  w e r e  p r e s c r i b e d  p o s t - o p e r a t i ve ly  i n  HIV pos i t i ve  pa t i en t s  
u n t i l  t h e  s e p s i s  w as  c o n t r o l l e d .   
P a t i e n t s  w e r e  r e v i e w e d  e ve r y  t w o  w e e k s  a f t e r  t h e  p r o c e d u r e  
u n t i l  t h e  p a t i e n t  be c a me  p a i n  f r e e ,  an d  t h e r e  w a s  n o  d i s c h a r ge  
o r  t e n d e r n e s s  a t  t he  su rg i ca l  wound .   
F i g u r e s  4 . 7 ,  4 . 8 ,  4 . 9  a n d  4 . 1 0  s h o w  t h e  h e a l i n g  t i me  a f t e r  t h e  
p r o c e d u r e .   
T e n  H I V  p o s i t i ve  p a t i e n t s  w i t h  a n a l  u l c e r  n ee d e d  mor e  t h a n  s i x  
weeks  fo r  hea l i ng  o f  t he  su rg i ca l  w o u n d  t o  o c c u r  a n d  a l l  o f  
t h e m h a d  a d v a n c e d  H I V  d i s e a s e ,  i e .  s t age s  I I I  and  IV .   
T h e  ma j o r i t y  o f  H I V  n e g a t i v e  p a t i e n t s  h e a l e d  i n  l e s s  t h a n  t h r ee  
w e e k s  a f t e r  t h e i r  ope r a t i o n  f o r  a n a l  f i s s u r e s .  
The  CD4  coun t  d id  no t  co r r e l a t e  w i th  hea l i ng  a f t e r  t he  


































































F i g u r e  4 . 1 0  H e a l i n g  v s  C D 4  c o u n t  a f t e r  t r e a t me n t  o f  a n a l  






P o s t - o p e ra t i v e  f a ec a l  i n c o n t i n e n ce  w a s  fo r t u n a t e l y  i n f r e q u e n t  
a f t e r  t r e a t me n t  o f  b o t h  c o nd i t i o n s .  O n e  H I V  + v e  p a t i e n t  w i t h  
a n a l  u l c e r  b eca me  s e v e r e l y  i n c o n t i n en t  a f t e r  l a t e r a l  
s p h i n c t e r o t o my  a n d  n e e d e d  t o  have  d ive r s i on  co lo s tomy .  Two  
pa t i e n t s  w i t h  ana l  f i s su r e ,  one  HIV  nega t i ve  and  one  s t age  I I I  
H I V ,  w e r e  a l so  i nc o n t i n e n t  a f t e r  l a t e r a l  s p h i n c t e r o t om y ,  b u t  
b o t h  r e c o v e r e d  f u l l y  a f t e r  a  f e w  w e e k s  o f  c o n s e r v a t i v e  
t r e a t me n t .  T h e r e  w e r e  f o u r  d e a t h s  i n  p a t i e n t s  w i t h  ana l  u l c e r s  
a n d  o n e  i n  t h e  a n a l  f i s s u r e  p a t i e n t s .  A l l  o f  t h e m w e r e  p a t i e n t s  
w i th  AIDS  and  t he i r  dea th s  we r e  u n r e l a t e d  t o  t h e  s u r g e r y .  
 
4 . 3 . 4  D i s c u s s i o n  
P a i n  i s  t h e  mo s t  c o m m o n  s y mp t o m  o f  H I V  p o s i t i v e  p a t i e n t s  
r equ i r i ng  ano rec t a l  su rge ry . 4  B o t h  a n a l  u l c e r s  a n d  f i s s u r e s  
p r e s e n t  w i t h  s e ve r e  pa i n  a n d  s i mi l a r  c l i n i c a l  p i c t u re s  e x c e p t  
t h a t  a n a l  u l c e r s  t e n d  t o  h a v e  a  w i d e r  u l c e r  b a s e  a n d  a  mo r e  
p rox ima l  pos i t i on  t han  ana l  f i s su r e s ,  cons i s t en t  w i th  p r ev ious  
r e p o r t s . 4 , 2 3 , 2 4   
M a n y  H IV  p o s i t i ve  p a t i e n t s  s u f f e r e d  f r o m c h r o n i c  d i a r r h o ea ,  
w h i c h  i s  r e c o g n i z e d  a s  a  p r e d i s p o s ing  f ac to r  f o r  ana l  f i s su r e s . 2 4  
I n  o u r  e xp e r i e nc e ,  1 1 %  o f  H I V  p o s i t i v e  p a t i en t s  p r e sen t e d  w i t h  





ma j o r i t y  o f  a n a l  u l c e r s  w e r e  s e e n  i n  t h e  a d v a n c e d  H I V  
ind iv idua l s  (Tab l e  4 . 12 ) .  
P r o c t a l g i a  a n d  r e c t a l  b l e e d i n g  we re  common  symptoms  i n  bo th  
cond i t i ons .  Howe ve r ,  no  HIV  n e g a t i v e  p a t i e n t s  h a d  a n a l  
i n c o n t i n e n c e  ( T a b l e  4 . 1 4  a n d  4 . 1 5 ) .  T h e  ma j o r i t y  o f  H I V  
p o s i t i ve  p a t i e n t s  ( 1 7 / 2 2 )  w i t h  a n a l  u l c e r s ,  b u t  o n l y  t w o  H IV  
p o s i t i ve  p a t i e n t s  w i t h  a n a l  f i s s u r e s  ( 2 / 1 1 ) ,  w e r e  i nc o n t i n e n t  
( p < 0 . 0 5 ) ,  a n d  a l l  o f  t h e m w e r e  a t  a d v a n c e d  H I V  s t a g e s .   
B o t h  a n a l  u l c e r s  a n d  f i s s u r e s  a r e  l o c a t e d  co m mo n l y  a t  t he  
pos t e r i o r  pa r t  o f  ana l  c ana l  i n  t h e se  pa t i e n t s .  Fo r  t he s e  r e a s o n s ,  
i t  c a n  be  d i f f i c u l t  t o  d i f f e r e n t i a t e  b e t w e e n  a na l  u l c e r s  a n d  
f i s s u r e s  i n  s o me  p a t i e n t s .  
T w o  c l i n i c a l  c r i t e r i a  a s s i s t  i n  ma k i n g  t h e  d i s t i nc t i o n  r e a d i l y  
a n d  r e l i a b l y :  t he  p r e s e n c e  o f  a  s en t i n e l  p i l e ,  a n d  t h e  a n a l  t o n e  
( me a s u r e d  d i g i t a l l y ) .  
A  s e n t i ne l  p i l e  w as  p r e se n t  i n  26 /35  HIV  nega t i ve  pa t i en t s  and  
4 / 1 1  H I V  p o s i t i ve  p a t i e n t s ,  b u t  i n  n o n e  o f  t h e  p a t i e n t s  w i t h  
a n a l  u l c e r  ( p < 0 . 0 0 0 1 ) .  
H i g h e r  a n a l  t o n e  w a s  d e t e c t e d  i n  29 /35  HIV  nega t i ve  pa t i en t s  
a n d  8 / 1 1  H I V  p o s i t i v e  p a t i en t s  w i t h  a n a l  f i s s u r e s ,  i n  c on t r a s t  t o  
1 3 / 2 2  H I V  p o s i t i ve  p a t i e n t s  w i t h  a n a l  u l c e r s  w h o  h a d  l o w  a n a l  
t o n e .  N o  a n a l  u l c e r s  p r e s e n t ed  w i th  h igh  ana l  t one  (p<0 .0001 )  




I n  a c c o r d a n c e  w i t h  t he  l i t e r a t u r e , 2 3 , 2 4  c o n s e r v a t i v e  t r e a t me n t  
w a s  s t a r t e d  fo r  b o t h  c o n d i t i o ns .  S u r g i ca l  t r e a t me n t  w a s  
r e se rved  fo r  t hose  no t  r e spond i n g  t o  c o n s e r v a t i v e  t r e a t me n t  
( T a b l e s  4 . 2 2  a n d  2 3 ) .  
I n  s i x  H IV  p o s i t i ve  p a t i e n t s ,  t h e  a na l  u l c e r s  w e r e  t r e a t e d  w i t h  
d e b r i d e me n t  a n d  s u t u r i n g  o f  t h e  u l c e r s .  T h e y  a c h i e v e d  b e t t e r  
p a i n  r e l i e f  a f t e r  o p e r a t i o n  a l t hough  hea l i ng  was  p ro longed  a f t e r  
t h e  p r oc e d u r e  ( >  6  w e e k s ) .  H o w e v e r ,  a f t e r  l a t e r a l  
s p h i n c t e ro t o my ,  o n e  H I V  p o s i t i ve  p a t i e n t  wi t h  a n  a na l  u l c e r  
d e v e l o p e d  s e v e r e  i n c o n t i n e n c e  a nd  no  pa in  r e l i e f  a t  a l l .  Fo r  
t hose  pa t i en t s  w i th  ana l  f i s su r e s ,  s even  HIV  pos i t i ve  pa t i en t s  
h a d  l a t e r a l  s p h i n c t e r o t o my  a n d  a l l  o f  t h e m h a d  i mp r o v e me n t  a s  
d i d  t h e i r  H I V  n e g a t i v e  c o u n t e r p a r t s .  L a t e r a l  s p h i n c t e r o t o my  
shou ld  no t  be  u sed  a s  a  su rg i c a l  t r e a t me n t  f o r  a n a l  u l c e r s .  
C o n c e r n i n g  h e a l i ng  a f t e r  su r g e r y ,  pa t i e n t s  wi t h  a d va nc e d  H I V  
a n d  l o w  C D 4  c o u n t  t e n d  t o  h a v e  d e l a y e d  h e a l i n g  t i me s .  
D u r i n g  t h e  f o l l o w - u p  p e r i o d ,  f o u r  H I V  p o s i t i ve  p a t i e n t s  w i t h  
a n a l  u l ce r s  a n d  o n e  H I V  p o s i t i ve  p a t i e n t  w i t h  a n a l  f i s s u r e  d i e d ;  
a l l  o f  t h e m w e r e  s u f f e r i n g  f r o m A I D S  ( i e .  s t a g e  I V  d i s e a s e ) .  
N o n e  o f  t h e  H I V  p o s i t i ve  p a t i e n t s  h a d  p o s t -o p e r a t i v e  s e p t i c  






4 .4  Per iana l  suppura t ion  
 
4 .4 .1  Demography  
N e a r l y  one  t h i r d  o f  b o t h  H I V  p o s i t i v e  a n d  n e g a t i ve  p a t i e n t s  
p r e s e n t e d  w i t h  p e r i a n a l  s u pp u r a t i on .  Rega rd l e s s  o f  HIV  s t a tu s ,  
pe r i ana l  suppu ra t i on  w a s  mo r e  c o m mo n  i n  ma l e s  ( T a b l e  4 . 2 4 ) .  
 
4 . 4 . 2  P re sen t a t i on  
4 . 4 . 2 . 1  S y mpt o ms  
T h e  ma i n  s y mp t o ms  w e r e  b o i l s  ( 26 /39  HIV  –ve  v s  12 /31  HIV 
+ v e ;  p = 0 . 0 2 ) ,  s p r e a d i n g  i n f e c t i o n  ( 1 / 3 9  H I V - v e  v s  3 / 3 1  H I V  
+ v e ;  p = 0 . 2 3 ) ,  d i s c h a r g e  ( 1 1 /39  HIV  –ve  v s  11 /31  HIV  +ve ;  
p = 0 . 5 1 )  a n d  i n c o n t i n e n c e  ( 0 /39  HIV  –ve  v s  4 /31  HI V  +ve ;  
p=0 .034 )  (Tab l e  4 . 25 ) .  
 
4 . 4 . 2 . 2  P a s t  me d i c a l  a n d  s o c i a l  h i s t o r y  
N o  f e ma l e  p a t i e n t s  h a d  a  b a d  o b s t e t r i c  h i s t o r y  a n d  n o n e  h a d  
p r a c t i s e d  a n a l  r e c ep t i v e  i n t e r c o u r s e .  
 
4 . 4 . 2 . 3  Phys i ca l  s i gns  
E igh t een  HIV  nega t i ve  pa t i en t s  a n d  t w en t y  H I V  p o s i t i ve  
pa t i en t s  had  o the r  pa tho log i e s ,  s u c h  a s  p i l o n id a l  s i n us ,  




f i n d i n g s  w e r e  s i mi l a r  i n  b o t h  H I V  n e g a t i v e  a n d  p o s i t i ve  
i nd iv idua l s ,  excep t  e i gh t  advan c e d  H I V  p o s i t i v e  p a t i e n t s  h a d  
a b n o r ma l l y  w e a k  a n a l  t o n e  ( T a b l e  4 . 2 6 ) .  
 
4 . 4 . 2 . 4  I n v e s t i g a t i o n s  
Th ree  HIV  nega t i ve  pa t i en t s  w i t h  s e p s i s  we r e  d i a g n o s e d  a s  
d i a b e t i c .  S i x  o f  t h e  s t age  I V  H I V  p o s i t i ve  p a t i e n t s  had  
a b n o r ma l  b l o o d  r e s u l t s ,  a  l o w  a l b u mi n  l e v e l .  O n e  s t a ge  I I I  H I V  
p o s i t i ve  p a t i e n t  w a s  s y p h i l i s  s e r o l og y  r e a c t i v e .  T w o  p a t i e n t s  
( o n e  H I V  n e g a t i v e  a n d  t h e  o t h e r  s t age  I I I  H IV  p o s i t i ve )  w i t h  
m u l t i p l e  a b s c e s s e s  w e r e  f o u n d  t o  h a ve  myc o b a c t e r i u m i n f e c t i o n  
o n  t h e i r  p u s  s w a b .   
 
4 . 4 . 3  T r e a t me n t  a n d  i t s  o u t c o me  
E v e r y  p a t i e n t  w a s  t r e a t e d  a s  a  s u r g i c a l  e me r g e n c y .   
T h e  t r e a t me n t  w a s  i n d i v i d u a l i ze d  d e p e n d i n g  o n  t h e  t y p e  o f  
pa tho logy ,  s eve r i t y  o f  t he  s eps i s  and  t he  pa t i en t ’ s  gene ra l  
c o n d i t i o n  ( T a b l e  4 . 2 7 ) .  P e r i -ope ra t i ve  an t i b io t i c s  ( A u g me n t i n ® )  
w e r e  g i v e n  t o  e v e r y  p a t i e n t  r o u t i ne l y .  
E a c h  p a t i e n t  w a s  r e v i e w e d  e ve r y  t w o  w e e k s  a f t e r  s u r g e r y .   
Two  o f  t he  s t age  IV  HIV in f ec t ed  pa t i en t s  d i ed  du r ing  t he  
c o u r s e  o f  f o l l o w - u p  d u e  t o  t h e i r  p o o r  g e n e r a l  c o n d i t i o n ,  





T e n  a d v a n c e d  H I V  s t a g e  ( s t a g e  I I I  a n d  I V )  p a t i e n t s ,  o n e  H I V  
n e g a t i v e  a n d  o n e  e a r l y  H I V  s t a g e  ( s t a g e  I I )  h e a l e d  s i x  w e e k s  
a f t e r  o p e r a t i o n .  A d v a n c e d  H I V  s t age  p r ed i c t ed  l onge r  hea l i ng  
t i me  ( p < 0 . 0 0 1 ) .  T e n  H I V  p o s i t i ve  p a t i e n t s  w i t h  C D 4  c o u n t  mor e  
t han  500 /µ l  ( 10 /14 )  hea l ed  wi t h i n  t h r e e  w e e k s  ( F i g u r e s  4 . 1 1  
and  4 .12 ) .  




T a b l e  4 . 2 4  A g e  a n d  H I V  s t a t u s  o f  pa t i e n t s  wi t h  p e r i a n a l   
                 s u p p u r a t i o n  
 
HIV Male Female Age: median (range)  
Negative 27 12 40 y (5-70) 
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23 8 34 y (16-52) 
 
 
T a b l e  4 . 2 5  S y m p t o m s  o f  p e r i a n a l  s up p u r a t i o n  
                      
HIV Boils Spreading 
infection 
Discharge Ulcer “pile” Incontinence 
Negative 26 1 11 - 2 - 
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T a b l e  4 . 2 6  F i n d i n g s  i n  p e r i a n a l  s u p p u r a t i o n                            
 
Findings HIV negative HIV stage II HIV stage III HIV stage IV 
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Low anal tone 
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T a b l e  4 . 2 7  T r e a t m e n t  o f  p e r i a n a l  s up p u r a t i o n  
 
                           

































































































































F i g u r e  4 . 1 1  T i me  t o  H e a l i n g  a f t e r  t r e a t me n t  o f  p e r i a n a l  



















F i g u r e  4 . 1 2  H e a l i n g  v s  C D 4  a f t e r  t r ea t me n t  o f  p e r i a na l  
suppu ra t i on  
(To t a l s  i n  F igu re  4 .12  a r e  n o t  t h e  s a m e  a s  F i g u r e  4 . 1 1  b e c a u s e  
s o me  p a t i e n t s  h a d  d u a l  p a t h o l o g i e s )  
 
 50
4 . 4 . 3  D i s c u s s i o n  
I t  i s  we l l  r e cogn i zed  t ha t  a  ma j o r  c a u s e  o f  mor b i d i t y  a n d  
m o r t a l i t y  i n  t h e  i m m u n o c o m p r o mi s e d  p a t i e n t  i s  i n f e c t i o n  a n d  
up  t o  34% o f  HIV  in f ec t ed  pa t i e n t s  h a v e  b e e n  r e po r t e d  a s  
hav ing  f i s t u l a - i n - ano  an d  p e r i a n a l  a b sc e s s . 8 , 2 5  I n  t h i s  s t u d y ,  o n e  
t h i rd  o f  pa t i en t s ,  r ega rd l e s s  o f  H I V  s t a t us ,  p r e s e n t e d  w i t h  
p e r i a na l  s u p p u r a t i o n .  H o w e v e r ,  mu l t i p l e  a bs c e s s e s ,  s p r e a d i ng  
i n f e c t i o n ,  s u c h  a s  n e c r o t i z i n g  f a s c i t i s ,  a n d  i n c o n t i n e n c e  w e r e  
m o r e  c o m m o n  i n  a d v a n c e d  H I V  s t a g e d  p a t i e n t s  ( T a b l e s  4 . 2 5  a n d  
4 . 2 6 ) .  
I n  t h e  l i t e r a t u r e ,  t h e r e  i s  a  co n s e n s u s  r e g a r d i n g  t h e  i m p o r t a n c e  
o f  t h e  p r o p e r  ma n a g e me n t  o f  p e r i a n a l  s e p s i s  i n  
i m m u n o c o mp r o mi s e d  p a t i e n t s .  A l though  mos t  su rgeons  
r ecomme nd  i nc i s i on  and  d r a inage  f o r  p e r i a n a l  s u p p u r a t i o n ,  
t h e r e  wa s  c o n t r o v e r s y  a b o u t  t h e  p r o p e r  ma n a g e me n t  o f  
a s s o c i a t e d  f i s t u l a .  S o me  s u r geons ,  conce rned  abou t  p ro longed  
o r  ab sen t  wound  hea l i ng  and  i ncon t i nence ,  advoca t e  a  
c o n s e r v a t i v e  a p p r o a c h .  O t h e r s  b e l i e v e  t h a t  t h e  f i s t u l a  s h o u l d  b e  
t r e a t e d  a t  t h e  t i me  o f  d r a i n a g e  a s  i n  t h e  g e n e ra l  
popu l a t i on . 2 2 , 2 5 , 2 6   
I n  o u r  e x p e r i e n c e ,  f o u r  a d v a n c e d  H I V  i n f e c t e d  p a t i e n t s  h a d  
p r e o p e r a t i v e  i n c on t i n e n c e  a n d  e i gh t  a d v a nc e d  H I V  i n f e c t e d  




pa t i en t s  su f f e r e d  pos tope ra t i ve  sph inc t e r  damage  and  
i ncon t i nence .  As  shown  in  t he  Tab l e  4 . 27 ,  e i gh t  HIV  pos i t i ve  
p a t i e n t s  h a d  p r i ma r y  f i s t u l o t o my  a n d  t wo  a d v a n c e d  H I V 
p o s i t i ve  p a t i e n t s  h a d  s e t o n  s u t u re .  A l l  o f  t he m a c h i e v e d  c o n t ro l  
o f  s e p s i s  a n d  t h e r e  w a s  n o  r e c u r r e n c e  o f  s e p s i s  a f t e r  t he  
t r e a t me n t .   
O n e  H I V  n e g a t i v e  p a t i e n t  a n d  t h r ee  a d v a n ce d  H I V  p o s i t i ve  
p a t i e n t s  n e e d e d  a  c o l o s t o my  d u e  t o  s e v e r e  s e p s i s .  A l t h o u g h  t w o  
H I V  p a t i e n t s  d i e d  a s  a  r e su l t  o f  t he i r  p o o r  g e n e r a l  c o n d i t i o n ,  
t h e  s e p s i s  w a s  w e l l  c o n t r o l l e d  a f t e r  c o l o s t o my .  
Advanced  HIV  in f ec t i on  and  a  l ow  CD4  coun t  we re  t he  ma in  
c a u s e s  o f  d e l a y e d  w o u n d  h e a l i n g  i n  o u r  e x p e r i e n c e  ( F i g u r e s  
4 . 1 1  a n d  4 . 1 2 ) .  N o n e  o f  p a t i e n t s  w i t h  C D 4  c o u n t  m o r e  t h a n  
5 0 0 / µ l  t o o k  l o n g e r  t o  h e a l  t h a n  s i x  weeks ,  bu t  t en  advanced  












4 . 5  A n a l  c a n c e r s  an d  wa r t s  
 
Four  HIV  nega t i ve  pa t i en t s  had  ana l  ma l i gnanc i e s :  one  
s q u a mo u s  c e l l  c a r c i n o ma  ( S C C )  an d  t h r e e  a d e n o c a r c i n o ma  ( o n e  
o f  t h e  l a t t e r  w a s  a  c a n ce r  a r i s i ng  in  a  f i s t u l a ) .  I n t e r e s t i n g l y ,  
t h e r e  w e r e  n o  a n a l  ma l i g n a n c i e s  i n  t h e  1 0 0  c o n s e c u t i v e  H I V  
p o s i t i ve  p a t i e n t s  w i t h  a n o re c t a l  s y m p t o ms  i n  t h i s  s e r i e s .  
F o u r  p a t i e n t s  h a d  a n a l  w a r t s  a n d  a l l  o f  t h e m u n d er w e n t  e x c i s i o n  
b i o p s i e s  w h i c h  s ho w e d  b e n i g n  h i s t o l o g y  w i t h  h u ma n  p a p i l l o ma  
v i r u s  ( H P V )  i n f e c t i o n .  Th ree  o f  t hem were  a t  t he  advanced  HIV  
s t a g e ,  t wo  a t  s t a ge  I I I  a n d  o n e  a t  s t a g e  I V .  A l l  H I V  p o s i t i ve  
p a t i e n t s  h a d  d e l a y e d  h e a l i n g  l o n g e r  t han  s i x  weeks  a f t e r  wa r t  
e x c i s i o n .  T w o  H I V  p o s i t i ve  p a t i e n t s  r e c u r r ed  s i x  w e e k s  a f t e r  
e x c i s i o n .  
 
4 . 5 . 1  D i s c u s s i o n  
I n  t h e  l i t e r a t u r e ,  H I V  p o s i t i v e  pa t i en t s  h a v e  a  h i g h e r  r i s k  fo r  
a n a l  ma l i g n a n c i e s ,  p a r t i c u l a r l y  squamous  ce l l  c a r c inoma  o f  t he  
a n u s  ( S C C A ) . 1 1  H o w e v e r ,  t h i s  w a s  n o t  s o  i n  o u r  e x p e r i e n c e .  
A l t h o u g h  H I V  s t a t u s  h a d  n o t  b e e n  l i nked  w i th  t he  pa t i en t ’ s  
h i s t o logy  fo r  e t h i ca l  r e a sons ,  t he r e  w e r e  o n l y  s i x t e e n  r e c o r d e d  
c a s e s  o f  S C C A  f r o m  2 0 0 0  t o  2 0 0 7  a t  t h e  C h r i s  H a n i  
B a r a g w a n a t h  H o s p i t a l ,  t h e  m a i n  r e f e r r a l  c e n t r e  fo r  S o w e t o  w i t h   
i t s  p o p u l a t i o n  o f  o v e r  one  mi l l io n .  ( D a t a  c o u r t e s y  o f  t he  
D e p a r t me n t  o f  A n a t o mi c a l  P a t h o l o g y ,  C h r i s  H a n i  B a r a g w a n a t h  
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H o s p i t a l . )  I n  o u r  e x p e r i e n ce ,  SC C A  i s  a n  u n c o m mo n  p a t h o l o g y  
i n  b o t h  H I V  p o s i t i v e  a n d  n e g a t i v e  p a t i e n t s .  
T h e  s c a r c i t y  o f  S CC A  i s  n o t  me r e l y  a  fu n c t i o n  o f  r e f e r r a l  b i a s -  
i . e .  t h a t  p a t i e n t s  mi g h t  n o t  c h o o s e  t o  be  t r e a t ed  i n  Sowe to  o r  i n  
p u b l i c  hos p i t a l s .  I t  i s  s t i l l  a n  unc o m m o n  d i s e a se  i n  S o u t h  
A f r i c a , 2 7  de sp i t e  t he  r avages  o f  HIV .  T h e  C e n t r a l  L a b o r a t o r y  o f  
t h e  N H L S  a t  t h e  J o h a n n e s b u r g  H o s p i t a l  ( w h i c h  s e r ves  t h e  r e s t  
o f  t h e  Wi t w a t e r s r a n d ,  a s  w e l l  a s  h o s p i t a l s  f r o m  K l e r k s d o r p  a n d  
N e l s p r u i t ,  w i t h  a  p o p u l a t i o n  a t  l ea s t  t en  t ime s  t ha t  o f  Sowe to )  
on ly  d i agnosed  on  ave rage  on ly  12  ca se s  pe r  yea r  du r ing  t he  
s a me  p e r i o d  ( 2 0 0 1 - 2 0 0 7 ) .   
D u e  t o  t h e  s t r o n g  a s s o c i a t i o n  b e t w e e n  a n o r e c t a l  h u ma n  
pap i l l oma  v i ru s  (HPV)  i n fe c t i o n  a nd  S C C A , 2 7  e ac h  p a t i e n t  w i t h  
ana l  wa r t s  was  o f f e r ed  exc i s i on  b iopsy .  Advanced  HIV  pa t i en t s  
h a d  d e l a y e d  w o u n d  h e a l i n g  a n d  h a l f  o f  t hem r ecu r r ed  a f t e r  s i x  
weeks  a f t e r  su rge ry .  A l though  o u r  s a mp l e  h a d  o n l y  a  s ma l l  
n u mb e r  o f  p a t i e n t s ,  w e  a g r e e  w i t h  t h e  l i t e r a t u r e  t h a t  an o r e c t a l  
c o n d y l o m a t a  i n  i m m u n o d e f i c i e n t  p a t i e n t s  a r e  m o r e  a g g r e s s i v e ,  
w i t h  h i g h  r e c u r r e n c e s  and  pos s ib l e  h igh  neop l a s t i c  







5  C O N C L U S I O N  
 
O u r  e x p e r i e n c e  c o n f i r ms  t h a t  o f  o t h e r  w o r k e r s  i n  t h e  f i e l d ,  i n  
w h i c h  c o n s e r v a t i ve  t r ea t me n t  i s  p r e f e r a b l e  i n  p a t i e n t s  a t  t he  
a d v a n c e d  H I V  s t a g e s ,  I I I  a n d  I V .  H o w e v e r ,  p r o c e d ur e  r e l a t ed  
s ep t i c  comp l i ca t i ons  d id  no t  oc c u r  i n  o u r  s t u d y  p a t i e n t s .   
A  pos s ib l e  r e a son  was  t he  u sag e  o f  a n t i r e t r o v i r a l  d r u g s  a n d  
p r e o p e r a t i v e  a n t i b i o t i c s ,  w h i ch  migh t  p r even t  t he  s ep t i c  
c o mp l i c a t i o n s  a n d  ma d e  t h e  s u r g i c a l  p r o c e d u r e s  s a f e r ,  
e s p e c i a l l y  a f t e r  h a e mo r r h o i de c t o my  a n d  r u b b e r  b a n d  l i g a t i o n .  
A d v a n c e d  H I V  s t a g e s  p r e d i c t  l o n g e r  h e a l i n g  t i me  e x c e p t  i n  
p a t i e n t s  w i t h  a n a l  f i s t u l a ,  i n  whom the  t y pe  of  f i s t u l a  i s  t he  
ma i n  f a c t o r  o f  d e l a y e d  w o u n d  h e a l i n g .  
Whe n  c o m p a r i n g  t h e  d i s t r i b u t i o n  o f  mu l t i p l e  v e r s u s  c o mpl e x  
f i s t u l a s ,  H I V  p o s i t i v e  p a t i en t s  w e r e  m o r e  l i ke l y  t o  s u f f e r  f r o m  
m u l t i p l e  f i s t u l a s ,  e s p e c i a l l y  a t  t h e  a d v a n c e d  s t a g e s  a nd  i mp l y  a  
poo r  p rognos i s ,  wh i l e  complex  f i s t u l a s  w e r e  mor e  c o m m o n l y  
s e e n  i n  HI V  n e g a t i v e  p a t i e n t s .  
B o t h  a n a l  u l c e r  a n d  f i s s u r e  a r e  c o m m o n  i n  H I V  p o s i t i ve  
p a t i e n t s  a n d  c a r e f u l  p h y s i c a l  e xamina t i on  can  d i f f e r en t i a t e  
be tween  t he se  two  con fus ing  pa th o l og i e s .  We a k  a n a l  t o n e  a n d  
a b s e n c e  o f  s e n t i n e l  p i l e  a r e  t he  p a t h o g n o mo n i c  f i n d i n g s  i n  a n a l  
u l c e r  a nd  t h e  c o n t r a r y  i s  t r u e  i n  a n a l  f i s s u r e .  L a t e r a l  
s p h i n c t e r o t o my  i s  a  r e l a t i v e l y  s a f e  p r o c e d u r e  fo r  a n a l  f i s s u r e .  
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H o w e v e r ,  i t  i s  c on t r a i n d i ca t e d  i n  an a l  u l c e r  o f  H I V  p o s i t i ve  
p a t i e n t s .  O u r  e x p e r i e n c e  s h o w e d  t h a t  H I V  r e l a t e d  a n a l  u l c e r s  
a r e  a s s o c i a t e d  w i t h  a b n o r ma l l y  w e a k  a n a l  t o n e  a n d  
s p h i n c t e r o t o my  c a n  r i s k  f u r t h e r  s p h i n c t e r  d a m a g e .  
Pe r i ana l  suppu ra t i on  i s  a  su rg i ca l  emergency  i n  
i m m u n o c o mp r i s e d  p a t i e n t s  d u e  t o  h i g h  mo r b i d i t i e s  a n d  
m o r t a l i t i e s .  A s s o c i a t e d  f i s t u l a  c a n  be  t r e a t e d  s i mi l a r l y  i n  b o t h  
HIV  nega t i ve  and  pos i t i ve  pa t i e n t s  w i t h o u t  i n c r e a s e d  
c o mpl i c a t i o n s .  
I n  o u r  e x p e r i e n c e ,  a n a l  ma l i g n anc i e s ,  e s p e c i a l l y  S C C A ,  a r e  
u n c o m m o n  i n  H I V  p o s i t i ve  p a t i e n t s .     
        

























 Append ix  C  
CDC c l a s s i f i c a t i on  o f  HIV  i n f ec t i on x  
S t a g e  I                  A c u t e  i n f e c t i o n  
S t a g e  I I                 I n f e c t i o n  w i t h o u t  s y mp t o ms +  
S t a g e  I I I               P e r s i s t e n t  g e n e r a l i z e d  l y mp h a d e n o p a t h y  
S t a g e  I V               O t h e r  d i s e a s e s  
(A)  C o n s t i t u t i o n a l  d i s ea s e  
(B)  Neuro log i c  d i s ea se  
(C)  S e c o n d a r y  i n f e c t i o u s  d i s e a s e s  
(D)  S e c o n d a r y  c a n c e r s +  
( E )  O t h e r  c o n d i t i o n s   
  
 
x  : A d a p t e d  f r o m t h e  C e n t r e s  f o r  D i s e a s e  C o n t r o l  ( C D C )                            
    C l a s s i f i c a t i o n  s y s t e m 4  
 
+  :  P a t i e n t s  i n  s t a ge s  I I  a n d  I V  ma y  be  sub -c l a s s i f i ed       
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